National Research Corp
Buy, Hold or Sell?

Let's analyse National Research Corp together

Penke I guess you are interested in National Research Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of National Research Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about National Research Corp

I send you an email if I find something interesting about National Research Corp.

Quick analysis of National Research Corp (30 sec.)

What can you expect buying and holding a share of National Research Corp? (30 sec.)

How much money do you get?

$1.47

When do you have the money?

1 year

How often do you get paid?

92.5%

What is your share worth?

Current worth

$1.99

Expected worth in 1 year

$1.08

How sure are you?

82.5%

+ What do you gain per year?

Total Gains per Share

$0.56

Return On Investment

1.7%

For what price can you sell your share?

Current Price per Share

$32.87

Expected price per share

$29.39 - $35.20

How sure are you?

50%

1. Valuation of National Research Corp (5 min.)

Live pricePrice per Share (EOD)

$32.87

Book Value per Share

$1.99

Intrinsic Value Per Share

$-3.06 - $13.37

Total Value Per Share

$-1.06 - $15.37

My calculation of the intrinsic value of National Research Corp is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.28) 3Y: ($0.30) TTM: ($0.23)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.00) 3Y: ($-0.02) TTM: ($0.02)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.89	$1.21	$0.80 - $1.26
2	$1.43	$2.45	$0.47 - $1.33
3	$1.65	$3.73	$0.14 - $1.41
4	$1.60	$5.04	$-0.19 - $1.48
5	$1.29	$6.37	$-0.52 - $1.56
6	$0.77	$7.73	$-0.85 - $1.63
7	$0.05	$9.12	$-1.18 - $1.71
8	$-0.84	$10.52	$-1.52 - $1.78
9	$-1.88	$11.94	$-1.85 - $1.86
10	$-3.06	$13.37	$-2.18 - $1.93

2. Growth of National Research Corp (5 min.)

Is National Research Corp growing?

	Current year	Previous year	Grow	Grow %
How rich?	$48.9m	$72.4m	-$7.6m	-11.8%

How much money is National Research Corp making?

	Current year	Previous year	Grow	Grow %
Making money	$7.7m	$7.9m	-$206.2k	-2.7%
Net Profit Margin	20.8%	21.0%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of National Research Corp (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

Richest
#56 / 120

Most Revenue
#54 / 120

Most Profit
#16 / 120

Most Efficient
#9 / 120

What can you expect buying and holding a share of National Research Corp? (5 min.)

Welcome investor! National Research Corp's management wants to use your money to grow the business. In return you get a share of National Research Corp.

What can you expect buying and holding a share of National Research Corp?

First you should know what it really means to hold a share of National Research Corp. And how you can make/lose money.

Speculation

The Price per Share of National Research Corp is $32.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of National Research Corp.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in National Research Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.99. Based on the TTM, the Book Value Change Per Share is $-0.23 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.37 per quarter.

Based on historical numbers we can estimate the returns while holding a share of National Research Corp.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.36	1.1%	0.31	1.0%	0.32	1.0%	0.33	1.0%	0.36	1.1%
Usd Book Value Change Per Share	-0.35	-1.1%	-0.23	-0.7%	-0.11	-0.3%	0.06	0.2%	-0.02	-0.1%
Usd Dividend Per Share	0.12	0.4%	0.37	1.1%	0.21	0.6%	0.28	0.8%	0.22	0.7%
Usd Total Gains Per Share	-0.23	-0.7%	0.14	0.4%	0.10	0.3%	0.34	1.0%	0.20	0.6%
Usd Price Per Share	39.56	-	42.74	-	38.76	-	45.90	-	34.04	-
Price to Earnings Ratio	27.41	-	34.45	-	30.76	-	34.80	-	23.45	-
Price-to-Total Gains Ratio	-172.63	-	83.72	-	-2,128.87	-	-332.41	-	-163.26	-
Price to Book Ratio	19.84	-	16.75	-	13.46	-	24.23	-	17.60	-
Price-to-Total Gains Ratio	-172.63	-	83.72	-	-2,128.87	-	-332.41	-	-163.26	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	32.87
Number of shares	30

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.37	0.28
Usd Book Value Change Per Share	-0.23	0.06
Usd Total Gains Per Share	0.14	0.34
Gains per Quarter (30 shares)	4.20	10.16
Gains per Year (30 shares)	16.79	40.66

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	44	-27	7	33	7	31
2	88	-55	24	66	15	72
3	133	-82	41	100	22	113
4	177	-110	58	133	30	154
5	221	-137	75	166	37	195
6	265	-164	92	199	45	236
7	309	-192	109	232	52	277
8	354	-219	126	265	60	318
9	398	-247	143	299	67	359
10	442	-274	160	332	75	400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	39.0	1.0	0.0	97.5%	103.0	2.0	0.0	98.1%
Book Value Change Per Share	2.0	2.0	0.0	50.0%	8.0	4.0	0.0	66.7%	16.0	4.0	0.0	80.0%	32.0	8.0	0.0	80.0%	86.0	17.0	2.0	81.9%
Dividend per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	37.0	0.0	3.0	92.5%	73.0	0.0	32.0	69.5%
Total Gains per Share	3.0	1.0	0.0	75.0%	9.0	3.0	0.0	75.0%	17.0	3.0	0.0	85.0%	33.0	7.0	0.0	82.5%	91.0	13.0	1.0	86.7%

Fundamentals of National Research Corp

About National Research Corp

https://www.nrchealth.com
Health Information Services
435
1245 Q Street, Lincoln, NE, United States, 68508
Google Maps Bing Maps

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Fundamental data was last updated by Penke on 2024-04-10 22:32:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of National Research Corp.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit National Research Corp earns for each $1 of revenue.

Above 10% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
A Net Profit Margin of 23.3% means that $0.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of National Research Corp:

The MRQ is 23.3%. The company is making a huge profit. +2
The TTM is 20.8%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	23.3%	TTM	20.8%	+2.5%
TTM	20.8%	YOY	21.0%	-0.2%
TTM	20.8%	5Y	24.1%	-3.3%
5Y	24.1%	10Y	21.9%	+2.2%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	23.3%	-20.7%	+44.0%
TTM	20.8%	-20.0%	+40.8%
YOY	21.0%	-30.6%	+51.6%
5Y	24.1%	-35.6%	+59.7%
10Y	21.9%	-43.2%	+65.1%

Measures how much net profit National Research Corp earns for each $1 of revenue.

Revenue is the amount of profit National Research Corp generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit National Research Corp earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be used to compare companies within the Health Information Services industry.

You typically want a high profit margin. This means that for each $1 in sales, National Research Corp makes more profit. This shows the investor how efficiently National Research Corp is operating in general and compared to other companies in the same industry. National Research Corp operates in the Health Information Services industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of National Research Corp. If profit margins remain low (compared to the Health Information Services industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of National Research Corp is 0.23. This means that National Research Corp earned $0.23 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Health Information Services industry is -20.7%.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare National Research Corp with other companies in the same industry (Health Information Services).
Net profit margin should rise over the years.
Can be influenced when National Research Corp sells assets (profit will increase while costs remain the same).
It won’t show what part of National Research Corp is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of National Research Corp

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ National Research Corp = 8,858
Total revenue MRQ National Research Corp = 38,001
$8,858 / $38,001 = 0.23 or 23.3%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient National Research Corp is using its assets to generate profit.

Above 5% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
7.2% Return on Assets means that National Research Corp generated $0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of National Research Corp:

The MRQ is 7.2%. Using its assets, the company is efficient in making profit. +1
The TTM is 6.1%. Using its assets, the company is efficient in making profit. +1

Trends

Current period		Compared to		+/-
MRQ	7.2%	TTM	6.1%	+1.1%
TTM	6.1%	YOY	5.7%	+0.4%
TTM	6.1%	5Y	6.6%	-0.5%
5Y	6.6%	10Y	5.6%	+1.1%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	7.2%	-6.7%	+13.9%
TTM	6.1%	-6.5%	+12.6%
YOY	5.7%	-5.9%	+11.6%
5Y	6.6%	-6.2%	+12.8%
10Y	5.6%	-8.4%	+14.0%

Shows how efficient National Research Corp is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively National Research Corp is using its resources to generate profit. If the return on assets (7.2%) from National Research Corp are higher than the Health Information Services mean (-6.7%) that means National Research Corp is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of National Research Corp is 7.2%. This means the company generated $0.07 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Health Information Services industry is -6.7%.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example National Research Corp

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from National Research Corp = 8,858
Total assets MRQ (balance sheet) from National Research Corp = 122,437
8,858 / 122,437 = 0.07 or 7.2%

ROA is an important ratio as it will tell you how effectively National Research Corp is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient National Research Corp is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
18.1% Return on Equity means National Research Corp generated $0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of National Research Corp:

The MRQ is 18.1%. Using its investors money, the company is efficient in making profit. +1
The TTM is 12.6%. Using its investors money, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	18.1%	TTM	12.6%	+5.5%
TTM	12.6%	YOY	11.0%	+1.6%
TTM	12.6%	5Y	16.9%	-4.3%
5Y	16.9%	10Y	13.4%	+3.6%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	18.1%	-6.6%	+24.7%
TTM	12.6%	-7.2%	+19.8%
YOY	11.0%	-7.7%	+18.7%
5Y	16.9%	-9.6%	+26.5%
10Y	13.4%	-9.6%	+23.0%

Shows how efficient National Research Corp is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Health Information Services industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of National Research Corp is 18.1%. This means National Research Corp generated $0.18 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Health Information Services industry is -6.6%.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if National Research Corp existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of National Research Corp

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) National Research Corp = 8,858
Shareholders equity (balance sheet) MRQ National Research Corp = 48,955
8,858 / 48,955 = 0.18 or 18.1%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of National Research Corp.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient National Research Corp is operating .

Measures how much profit National Research Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
An Operating Margin of 30.8% means the company generated $0.31 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of National Research Corp:

The MRQ is 30.8%. The company is operating very efficient. +2
The TTM is 27.3%. The company is operating very efficient. +2

Trends

Current period		Compared to		+/-
MRQ	30.8%	TTM	27.3%	+3.5%
TTM	27.3%	YOY	30.7%	-3.4%
TTM	27.3%	5Y	31.5%	-4.2%
5Y	31.5%	10Y	30.1%	+1.3%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	30.8%	-20.9%	+51.7%
TTM	27.3%	-18.5%	+45.8%
YOY	30.7%	-22.8%	+53.5%
5Y	31.5%	-19.6%	+51.1%
10Y	30.1%	-31.6%	+61.7%

Measures how efficient National Research Corp is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit National Research Corp is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of National Research Corp is 30.8%. This means that National Research Corp earned $0.31 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Health Information Services industry is -20.9%.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of National Research Corp

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ National Research Corp = 11,709
Total revenue MRQ National Research Corp = 38,001
$11,709 / $38,001 = 0.31 or 30.8%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient National Research Corp is keeping operating costs low.

Below 1 is considered healthy (always compare to Health Information Services industry mean).
An Operation Ratio of 0.69 means that the operating costs are $0.69 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of National Research Corp:

The MRQ is 0.692. The company is efficient in keeping operating costs low. +1
The TTM is 0.731. The company is efficient in keeping operating costs low. +1

Trends

Current period		Compared to		+/-
MRQ	0.692	TTM	0.731	-0.039
TTM	0.731	YOY	0.693	+0.038
TTM	0.731	5Y	0.686	+0.044
5Y	0.686	10Y	0.702	-0.015

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.692	1.343	-0.651
TTM	0.731	1.383	-0.652
YOY	0.693	1.383	-0.690
5Y	0.686	1.394	-0.708
10Y	0.702	1.324	-0.622

Measures how efficient National Research Corp is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of National Research Corp is 69.2%. This means that National Research Corp earned $0.69 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Health Information Services industry is 1.34.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example National Research Corp

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(15,222 +11,070) \ 38,001 = 0.69

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of National Research Corp.

1.3. Liquidity

1.3.1. Current Ratio

Measures if National Research Corp is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
A Current Ratio of 0.67 means the company has $0.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of National Research Corp:

The MRQ is 0.673. The company is unable to pay all its short-term debts. -2
The TTM is 0.936. The company is just not able to pay all its short-term debts. -1

Trends

Current period		Compared to		+/-
MRQ	0.673	TTM	0.936	-0.263
TTM	0.936	YOY	1.367	-0.431
TTM	0.936	5Y	1.206	-0.270
5Y	1.206	10Y	1.365	-0.159

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.673	1.770	-1.097
TTM	0.936	1.811	-0.875
YOY	1.367	2.055	-0.688
5Y	1.206	2.582	-1.376
10Y	1.365	2.668	-1.303

Measures if National Research Corp is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for National Research Corp if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of National Research Corp is 0.67. This means National Research Corp has $0.67 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 1.77.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example National Research Corp

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
24,360 \ 36,203) = 0.67

The current ratio measures if National Research Corp is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if National Research Corp is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then National Research Corp does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate National Research Corp is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if National Research Corp is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
A Quick Ratio of 0.53 means the company can pay off $0.53 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of National Research Corp:

The MRQ is 0.532. The company is just not able to pay all its short-term debts with the most liquid assets. -1
The TTM is 0.891. The company is just not able to pay all its short-term debts with the most liquid assets. -1

Trends

Current period		Compared to		+/-
MRQ	0.532	TTM	0.891	-0.359
TTM	0.891	YOY	1.358	-0.467
TTM	0.891	5Y	1.128	-0.237
5Y	1.128	10Y	1.277	-0.148

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.532	1.059	-0.527
TTM	0.891	1.185	-0.294
YOY	1.358	1.813	-0.455
5Y	1.128	1.992	-0.864
10Y	1.277	2.044	-0.767

Measures if National Research Corp is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast National Research Corp can pay off its short term debts. This shows if National Research Corp can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of National Research Corp is 0.53. This means that National Research Corp can pay off $0.53 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is 1.06.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example National Research Corp

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio National Research Corp: (6,653 + 0 +12,623) / 36,203 = 0.53

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of National Research Corp.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of National Research Corp assets are financed with debt.

Below 1 (100%) is considered healthy but always compare National Research Corp to Health Information Services industry mean.
A Debt to Asset Ratio of 0.60 means that National Research Corp assets are financed with 60.0% credit (debt) and the remaining percentage (100% - 60.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of National Research Corp:

The MRQ is 0.600. The company is able to pay all its debts by selling its assets. +1
The TTM is 0.495. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.600	TTM	0.495	+0.105
TTM	0.495	YOY	0.478	+0.018
TTM	0.495	5Y	0.557	-0.062
5Y	0.557	10Y	0.473	+0.084

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.600	0.381	+0.219
TTM	0.495	0.385	+0.110
YOY	0.478	0.407	+0.071
5Y	0.557	0.411	+0.146
10Y	0.473	0.448	+0.025

Measures how much % of National Research Corp assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake National Research Corp than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare National Research Corp to Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of National Research Corp is 0.60. This means means that National Research Corp is financed with 60.0% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 177.0%.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why National Research Corp has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example National Research Corp

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
73,482 \ 122,437 = 60.0% or 0.60.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if National Research Corp is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
A Debt to Equity ratio of 150.1% means that company has $1.50 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of National Research Corp:

The MRQ is 1.501. The company is just able to pay all its debts with equity.
The TTM is 1.024. The company is able to pay all its debts with equity. +1

Trends

Current period		Compared to		+/-
MRQ	1.501	TTM	1.024	+0.477
TTM	1.024	YOY	0.917	+0.107
TTM	1.024	5Y	1.458	-0.434
5Y	1.458	10Y	1.185	+0.273

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	1.501	0.600	+0.901
TTM	1.024	0.578	+0.446
YOY	0.917	0.608	+0.309
5Y	1.458	0.718	+0.740
10Y	1.185	0.610	+0.575

Measures if National Research Corp is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of National Research Corp is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of National Research Corp is 1.50. This means that National Research Corp can pay off $1.50 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is 0.60.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example National Research Corp

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
73,482 \ 48,955 = 1.50 or 150.1%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of National Research Corp

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings National Research Corp generates.

Above 15 is considered overpriced but always compare National Research Corp to the Health Information Services industry mean.
A PE ratio of 27.41 means the investor is paying $27.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of National Research Corp:

The EOD is 22.773. Based on the earnings, the company is fair priced.
The MRQ is 27.408. Based on the earnings, the company is overpriced. -1
The TTM is 34.448. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	22.773	MRQ	27.408	-4.635
MRQ	27.408	TTM	34.448	-7.040
TTM	34.448	YOY	30.762	+3.686
TTM	34.448	5Y	34.801	-0.352
5Y	34.801	10Y	23.450	+11.350

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	22.773	-1.464	+24.237
MRQ	27.408	-2.160	+29.568
TTM	34.448	-1.939	+36.387
YOY	30.762	-3.761	+34.523
5Y	34.801	-4.657	+39.458
10Y	23.450	-5.128	+28.578

Measures how much money you pay for each share for every $1 in earnings National Research Corp generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare National Research Corp to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of National Research Corp is 27.41. This means the investor is paying $27.41 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is -2.16.
What is the trend?
The trend is important because it shows you how National Research Corp is performing over time. The most recent quarter might be important if National Research Corp released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for National Research Corp up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example National Research Corp

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 24,548 = EPS
PE ratio MRQ = 27.41

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of National Research Corp:

The EOD is 25.412. Based on how much money comes from the company's main activities, the company is underpriced. +1
The MRQ is 30.584. Based on how much money comes from the company's main activities, the company is fair priced.
The TTM is 50.178. Based on how much money comes from the company's main activities, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	25.412	MRQ	30.584	-5.172
MRQ	30.584	TTM	50.178	-19.594
TTM	50.178	YOY	37.659	+12.520
TTM	50.178	5Y	39.283	+10.895
5Y	39.283	10Y	34.973	+4.310

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	25.412	-1.643	+27.055
MRQ	30.584	-2.152	+32.736
TTM	50.178	-3.287	+53.465
YOY	37.659	-5.550	+43.209
5Y	39.283	-3.884	+43.167
10Y	34.973	-3.140	+38.113

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of National Research Corp is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Health Information Services industry mean).
A PB ratio of 19.84 means the investor is paying $19.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of National Research Corp:

The EOD is 16.482. Based on the equity, the company is expensive. -2
The MRQ is 19.837. Based on the equity, the company is expensive. -2
The TTM is 16.754. Based on the equity, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	16.482	MRQ	19.837	-3.355
MRQ	19.837	TTM	16.754	+3.083
TTM	16.754	YOY	13.460	+3.294
TTM	16.754	5Y	24.229	-7.475
5Y	24.229	10Y	17.602	+6.628

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	16.482	1.577	+14.905
MRQ	19.837	1.856	+17.981
TTM	16.754	1.880	+14.874
YOY	13.460	3.040	+10.420
5Y	24.229	3.953	+20.276
10Y	17.602	4.099	+13.503

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of National Research Corp.

3.1. Institutions holding National Research Corp

Institutions are holding 51.984% of the shares of National Research Corp.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Kayne Anderson Rudnick Investment Management LLC	12.0794	0.2852	2881464	-313165	-9.8029
2023-12-31	BlackRock Inc	4.467	0.0011	1065585	50002	4.9235
2023-12-31	Morgan Stanley - Brokerage Accounts	3.9561	0.0033	943710	3172	0.3373
2023-12-31	Vanguard Group Inc	3.9181	0.0008	934644	-46049	-4.6956
2023-12-31	Conestoga Capital Advisors, LLC	3.2732	0.4635	780806	7591	0.9817
2023-12-31	Dimensional Fund Advisors, Inc.	2.6679	0.0074	636402	7531	1.1975
2023-12-31	QV Investors Inc	1.6563	1.4085	395102	-56048	-12.4234
2023-12-31	Renaissance Technologies Corp	1.5661	0.0229	373584	6200	1.6876
2023-12-31	Geode Capital Management, LLC	1.4937	0.0015	356305	18227	5.3914
2023-12-31	State Street Corporation	1.4357	0.0007	342475	14842	4.5301
2023-12-31	Northern Trust Corp	1.1499	0.002	274294	-2919	-1.053
2023-12-31	Touchstone Capital, Inc.	1.0548	9.456	251625	-16736	-6.2364
2023-12-31	Comerica Bank	0.6505	0.0283	155174	-1218	-0.7788
2023-12-31	StonePine Asset Management Inc.	0.6418	0.0651	153100	86202	128.8559
2023-12-31	Bank of New York Mellon Corp	0.5112	0.001	121939	-9172	-6.9956
2023-12-31	Charles Schwab Investment Management Inc	0.4721	0.0011	112619	1185	1.0634
2023-12-31	Bank of America Corp	0.4464	0.0004	106492	-2057	-1.895
2023-12-31	Wells Fargo & Co	0.4143	0.001	98819	-1743	-1.7333
2023-12-31	Public Employees Retirement System Of Ohio	0.3661	0.0138	87325	0	0
2023-12-31	Royce & Associates, LP	0.3085	0.0269	73589	25000	51.452
Total		42.5291	11.7905	10145053	-229155	-2.3%

3.2. Funds holding National Research Corp

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Virtus KAR Small-Cap Growth I	8.8433	2.5147	2109518	-300000	-12.4506
2024-02-29	Vanguard Total Stock Mkt Idx Inv	2.4653	0.0015	588072	0	0
2024-01-31	Conestoga Small Cap Investors	2.3449	0.5733	559374	0	0
2024-02-29	Invesco Global Opportunities A	1.442	0.3891	343990	0	0
2024-02-29	iShares Russell 2000 ETF	1.3852	0.0214	330441	-54	-0.0163
2023-12-31	Virtus GF US Small Cap Focus I USD Acc	1.0281	2.8547	245247	0	0
2024-01-31	DFA US Micro Cap I	0.9332	0.1289	222620	0	0
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	0.9269	0.0087	221105	-259	-0.117
2023-12-31	Conestoga Small Cap Growth	0.9066	0.5252	216275	11258	5.4913
2024-01-31	IA Clarington Canadian Small Cap A	0.8229	1.2189	196290	-22327	-10.2128
2024-02-29	NBI Global Small Cap GP	0.6888	1.4127	164300	5500	3.4635
2023-12-31	Fidelity Small Cap Index	0.6041	0.0224	144115	1460	1.0234
2024-01-31	DFA US Small Cap I	0.5887	0.0376	140430	0	0
2024-02-29	NEI Canadian Small Cap Equity RS A	0.5452	1.2785	130060	-9640	-6.9005
2024-02-29	iShares Russell 2000 Growth ETF	0.5356	0.0454	127760	-149	-0.1165
2024-02-29	ODIN USA A NOK	0.4549	0.9056	108519	0	0
2023-12-31	JNL Multi-Manager Small Cap Growth A	0.4213	0.1712	100507	-3000	-2.8984
2024-02-29	State St Russell Sm/Mid Cp® Indx NL Cl C	0.3996	0.0092	95315	1300	1.3828
2024-01-31	Fidelity Extended Market Index	0.3372	0.0089	80431	1223	1.544
2023-12-31	Royce Micro Cap Trust	0.3004	0.5447	71668	25000	53.5699
Total		25.9742	12.6726	6196037	-289688	-4.7%

3.3. Insider Transactions

Insiders are holding 37.219% of the shares of National Research Corp.

Date	Owner	Type	Amount	Price
2024-01-04	Amandla Mk Trust	SELL	4600	41.22
2024-01-02	Amandla Mk Trust	SELL	201100	40.31
2023-12-13	Amandla Mk Trust	SELL	3779	41.55
2023-12-11	Amandla Mk Trust	SELL	37638	41.55
2023-12-08	Amandla Mk Trust	SELL	12328	41.55
2023-12-06	Amandla Mk Trust	SELL	952	41.6
2023-12-04	Amandla Mk Trust	SELL	100	41.6
2023-11-22	Amandla Mk Trust	SELL	627	42.08
2023-11-20	Amandla Mk Trust	SELL	57	42.1
2023-11-15	Amandla Mk Trust	SELL	403	42.1
2023-10-11	Amandla Mk Trust	SELL	1601	44.91
2023-06-26	Amandla Mk Trust	SELL	200	45.19
2023-06-23	Amandla Mk Trust	SELL	1891	45.04
2023-06-20	Amandla Mk Trust	SELL	18946	45.01
2023-06-16	Amandla Mk Trust	SELL	29227	45.04
2023-06-14	Amandla Mk Trust	SELL	3000	45.05
2023-06-12	Amandla Mk Trust	SELL	1800	45.05
2023-06-09	Amandla Mk Trust	SELL	5288	45.04
2023-06-07	Amandla Mk Trust	SELL	16344	46.34
2023-06-05	Amandla Mk Trust	SELL	1200	45.11

4. Summary

4.1. Key Performance Indicators

The key performance indicators of National Research Corp compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	-0.349	-0.228	-35%	-0.107	-69%	0.062	-660%	-0.023	-93%
Book Value Per Share	-	-	1.994	2.625	-24%	2.892	-31%	2.336	-15%	2.692	-26%
Current Ratio	-	-	0.673	0.936	-28%	1.367	-51%	1.206	-44%	1.365	-51%
Debt To Asset Ratio	-	-	0.600	0.495	+21%	0.478	+26%	0.557	+8%	0.473	+27%
Debt To Equity Ratio	-	-	1.501	1.024	+47%	0.917	+64%	1.458	+3%	1.185	+27%
Dividend Per Share	-	-	0.120	0.368	-67%	0.210	-43%	0.276	-57%	0.221	-46%
Eps	-	-	0.361	0.314	+15%	0.317	+14%	0.335	+8%	0.355	+2%
Free Cash Flow Per Share	-	-	0.323	0.226	+43%	0.264	+23%	0.320	+1%	0.282	+15%
Free Cash Flow To Equity Per Share	-	-	0.115	-0.186	+261%	-0.290	+352%	-0.010	+109%	-0.006	+105%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	1.000	0%	1.000	+0%
Intrinsic Value_10Y_max	-	-	13.371	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-3.055	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.208	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.890	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	3.731	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	1.653	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	6.374	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	1.293	-	-	-	-	-	-	-	-
Market Cap	784094128.000	-24%	971118880.000	1054644892.500	-8%	971202170.000	0%	1164749988.000	-17%	863181584.250	+13%
Net Profit Margin	-	-	0.233	0.208	+12%	0.210	+11%	0.241	-3%	0.219	+6%
Operating Margin	-	-	0.308	0.273	+13%	0.307	+0%	0.315	-2%	0.301	+2%
Operating Ratio	-	-	0.692	0.731	-5%	0.693	0%	0.686	+1%	0.702	-1%
Pb Ratio	16.482	-20%	19.837	16.754	+18%	13.460	+47%	24.229	-18%	17.602	+13%
Pe Ratio	22.773	-20%	27.408	34.448	-20%	30.762	-11%	34.801	-21%	23.450	+17%
Price Per Share	32.870	-20%	39.560	42.738	-7%	38.758	+2%	45.897	-14%	34.041	+16%
Price To Free Cash Flow Ratio	25.412	-20%	30.584	50.178	-39%	37.659	-19%	39.283	-22%	34.973	-13%
Price To Total Gains Ratio	-143.435	+17%	-172.628	83.719	-306%	-2128.872	+1133%	-332.411	+93%	-163.258	-5%
Quick Ratio	-	-	0.532	0.891	-40%	1.358	-61%	1.128	-53%	1.277	-58%
Return On Assets	-	-	0.072	0.061	+19%	0.057	+26%	0.066	+9%	0.056	+30%
Return On Equity	-	-	0.181	0.126	+44%	0.110	+64%	0.169	+7%	0.134	+35%
Total Gains Per Share	-	-	-0.229	0.140	-264%	0.103	-323%	0.339	-168%	0.198	-216%
Usd Book Value	-	-	48955000.000	64810500.000	-24%	72477250.000	-32%	59085950.000	-17%	67426775.000	-27%
Usd Book Value Change Per Share	-	-	-0.349	-0.228	-35%	-0.107	-69%	0.062	-660%	-0.023	-93%
Usd Book Value Per Share	-	-	1.994	2.625	-24%	2.892	-31%	2.336	-15%	2.692	-26%
Usd Dividend Per Share	-	-	0.120	0.368	-67%	0.210	-43%	0.276	-57%	0.221	-46%
Usd Eps	-	-	0.361	0.314	+15%	0.317	+14%	0.335	+8%	0.355	+2%
Usd Free Cash Flow	-	-	7938000.000	5583500.000	+42%	6607500.000	+20%	8125350.000	-2%	7129475.000	+11%
Usd Free Cash Flow Per Share	-	-	0.323	0.226	+43%	0.264	+23%	0.320	+1%	0.282	+15%
Usd Free Cash Flow To Equity Per Share	-	-	0.115	-0.186	+261%	-0.290	+352%	-0.010	+109%	-0.006	+105%
Usd Market Cap	784094128.000	-24%	971118880.000	1054644892.500	-8%	971202170.000	0%	1164749988.000	-17%	863181584.250	+13%
Usd Price Per Share	32.870	-20%	39.560	42.738	-7%	38.758	+2%	45.897	-14%	34.041	+16%
Usd Profit	-	-	8858000.000	7742750.000	+14%	7949000.000	+11%	8494950.000	+4%	6971000.000	+27%
Usd Revenue	-	-	38001000.000	37145000.000	+2%	37892000.000	+0%	35468050.000	+7%	31429250.000	+21%
Usd Total Gains Per Share	-	-	-0.229	0.140	-264%	0.103	-323%	0.339	-168%	0.198	-216%
	EOD	+5 -3	MRQ	TTM	+17 -18	YOY	+18 -17	5Y	+15 -20	10Y	+19 -17

4.2. Fundamental Score

Let's check the fundamental score of National Research Corp based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	22.773
Price to Book Ratio (EOD)	Between	0-1	16.482
Net Profit Margin (MRQ)	Greater than	0	0.233
Operating Margin (MRQ)	Greater than	0	0.308
Quick Ratio (MRQ)	Greater than	1	0.532
Current Ratio (MRQ)	Greater than	1	0.673
Debt to Asset Ratio (MRQ)	Less than	1	0.600
Debt to Equity Ratio (MRQ)	Less than	1	1.501
Return on Equity (MRQ)	Greater than	0.15	0.181
Return on Assets (MRQ)	Greater than	0.05	0.072
Total			5/10 (50.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of National Research Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	20.489
Ma 20	Greater than	Ma 50	36.903
Ma 50	Greater than	Ma 100	38.584
Ma 100	Greater than	Ma 200	39.285
Open	Greater than	Close	33.160
Total			1/5 (20.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	122,437
Total Liabilities	73,482
Total Stockholder Equity	48,955

	As reported
Total Liabilities	73,482
Total Stockholder Equity	+ 48,955
Total Assets	= 122,437

Assets

Total Assets	122,437
Total Current Assets	24,360
Long-term Assets	98,077

Total Current Assets

Total Current Assets (as reported)	24,360
Cash And Cash Equivalents	6,653
Net Receivables	12,623
Other Current Assets	5,084
Total Current Assets (calculated)	24,360
+/-	0

Long-term Assets

Long-term Assets (as reported)	98,077
Property Plant Equipment	30,265
Goodwill	61,614
Intangible Assets	1,471
Long-term Assets Other	4,727
Long-term Assets (calculated)	98,077
+/-	0

Liabilities & Shareholders' Equity

Total Current Liabilities	36,203
Long-term Liabilities	37,279
Total Stockholder Equity	48,955

Total Current Liabilities

Total Current Liabilities (as reported)	36,203
Short-term Debt	7,817
Short Long Term Debt	7,214
Accounts payable	1,301
Other Current Liabilities	12,251
Total Current Liabilities (calculated)	28,583
+/-	7,620

Long-term Liabilities

Long-term Liabilities (as reported)	37,279
Long term Debt	29,470
Long-term Liabilities Other	3,670
Long-term Liabilities (calculated)	33,140
+/-	4,139

Total Stockholder Equity

Total Stockholder Equity (as reported)	48,955
Common Stock	31
Retained Earnings	-30,530
Other Stockholders Equity	79,454
Total Stockholder Equity (calculated)	48,955
+/-	0

Other

Capital Stock	31
Cash and Short Term Investments	6,653
Common Stock Shares Outstanding	24,548
Current Deferred Revenue	14,834
Liabilities and Stockholders Equity	122,437
Net Debt	32,303
Net Invested Capital	85,639
Net Working Capital	-11,843
Property Plant and Equipment Gross	65,934
Short Long Term Debt Total	38,956

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

1997-06-30

1997-03-31

> Total Assets

0
0
0
22,600
23,100
25,400
24,200
26,300
25,900
25,300
27,200
29,300
30,527
32,005
32,323
31,637
31,896
33,088
33,198
33,772
34,166
35,910
37,261
33,772
41,848
43,159
43,375
45,673
46,262
46,595
46,228
47,954
48,708
48,365
49,226
44,675
44,222
61,747
60,265
61,532
61,532
63,292
64,041
61,869
62,194
61,169
60,764
72,145
73,334
72,264
74,406
72,499
77,384
78,824
93,400
95,770
98,003
100,298
100,952
100,676
103,378
105,594
109,429
100,046
103,502
104,899
109,914
110,996
116,277
121,868
127,063
129,510
128,452
131,048
129,476
129,099
118,370
116,499
119,301
120,624
126,059
124,576
128,740
127,316
130,976
102,885
108,717
107,684
104,571
104,275
107,649
110,685
115,855
116,781
127,246
133,423
146,878
151,849
156,186
157,540
153,154
136,233
134,983
130,461
134,306
133,627
120,136
122,437

122,437

120,136

133,627

134,306

130,461

134,983

136,233

153,154

157,540

156,186

151,849

146,878

133,423

127,246

116,781

115,855

110,685

107,649

104,275

104,571

107,684

108,717

102,885

130,976

127,316

128,740

124,576

126,059

120,624

119,301

116,499

118,370

129,099

129,476

131,048

128,452

129,510

127,063

121,868

116,277

110,996

109,914

104,899

103,502

100,046

109,429

105,594

103,378

100,676

100,952

100,298

98,003

95,770

93,400

78,824

77,384

72,499

74,406

72,264

73,334

72,145

60,764

61,169

62,194

61,869

64,041

63,292

61,532

60,265

61,747

44,222

44,675

49,226

48,365

48,708

47,954

46,228

46,595

46,262

45,673

43,375

43,159

41,848

33,772

37,261

35,910

34,166

33,772

33,198

33,088

31,896

31,637

32,323

32,005

30,527

29,300

27,200

25,300

25,900

26,300

24,200

25,400

23,100

22,600

> Total Current Assets

0
0
0
21,900
22,200
20,000
17,800
17,300
15,000
13,900
14,700
15,800
15,391
15,609
14,111
13,250
13,898
11,136
11,297
12,292
12,964
14,773
16,168
12,292
19,496
20,808
21,213
23,521
23,504
23,813
23,683
25,454
26,406
26,291
23,087
18,218
17,870
12,814
11,672
12,997
12,997
14,385
15,117
12,600
13,583
12,282
11,954
10,439
12,707
11,019
13,324
11,664
17,226
19,513
16,365
17,341
20,181
20,845
21,627
22,137
25,259
28,224
32,451
23,815
27,869
29,665
34,908
36,474
42,275
47,475
53,202
53,188
53,171
55,771
56,067
56,111
44,814
42,741
45,917
47,065
52,383
50,983
53,822
52,259
52,278
23,633
28,770
28,062
22,873
22,888
26,570
29,157
34,939
36,697
47,366
54,112
62,235
67,589
72,726
73,707
68,921
51,780
49,105
43,716
45,172
40,987
24,743
24,360

24,360

24,743

40,987

45,172

43,716

49,105

51,780

68,921

73,707

72,726

67,589

62,235

54,112

47,366

36,697

34,939

29,157

26,570

22,888

22,873

28,062

28,770

23,633

52,278

52,259

53,822

50,983

52,383

47,065

45,917

42,741

44,814

56,111

56,067

55,771

53,171

53,188

53,202

47,475

42,275

36,474

34,908

29,665

27,869

23,815

32,451

28,224

25,259

22,137

21,627

20,845

20,181

17,341

16,365

19,513

17,226

11,664

13,324

11,019

12,707

10,439

11,954

12,282

13,583

12,600

15,117

14,385

12,997

11,672

12,814

17,870

18,218

23,087

26,291

26,406

25,454

23,683

23,813

23,504

23,521

21,213

20,808

19,496

12,292

16,168

14,773

12,964

12,292

11,297

11,136

13,898

13,250

14,111

15,609

15,391

15,800

14,700

13,900

15,000

17,300

17,800

20,000

22,200

21,900

Cash And Cash Equivalents

0
0
0
4,700
3,900
1,400
900
4,900
2,200
2,500
1,100
1,100
330
3,724
4,912
3,219
2,673
1,137
2,924
1,080
1,233
1,870
1,658
1,080
1,257
2,698
3,947
3,441
5,226
3,942
2,543
3,648
5,326
3,125
1,036
844
1,031
575
1,387
876
876
2,122
2,059
3,355
1,486
1,309
677
1,109
620
404
1,460
2,512
6,261
7,236
3,195
3,519
3,316
4,464
6,223
8,082
7,872
11,168
15,026
8,286
9,234
10,802
18,934
22,092
26,453
31,539
39,063
40,042
37,010
40,555
37,580
42,145
25,366
27,192
28,878
33,021
34,664
31,628
35,750
34,733
35,478
6,698
7,273
12,991
2,641
4,020
8,358
13,517
10,021
11,957
21,855
34,690
43,454
48,899
52,482
54,361
47,290
32,974
28,392
25,026
23,724
22,496
3,828
6,653

6,653

3,828

22,496

23,724

25,026

28,392

32,974

47,290

54,361

52,482

48,899

43,454

34,690

21,855

11,957

10,021

13,517

8,358

4,020

2,641

12,991

7,273

6,698

35,478

34,733

35,750

31,628

34,664

33,021

28,878

27,192

25,366

42,145

37,580

40,555

37,010

40,042

39,063

31,539

26,453

22,092

18,934

10,802

9,234

8,286

15,026

11,168

7,872

8,082

6,223

4,464

3,316

3,519

3,195

7,236

6,261

2,512

1,460

404

620

1,109

677

1,309

1,486

3,355

2,059

2,122

876

1,387

575

1,031

844

1,036

3,125

5,326

3,648

2,543

3,942

5,226

3,441

3,947

2,698

1,257

1,080

1,658

1,870

1,233

1,080

2,924

1,137

2,673

3,219

4,912

3,724

330

1,100

2,500

2,200

4,900

900

1,400

3,900

4,700

Short-term Investments

0
0
0
0
0
0
0
0
0
7,300
10,700
10,900
11,753
7,624
5,990
6,577
7,718
6,027
5,025
6,637
7,124
7,435
8,932
6,637
10,858
11,089
12,155
12,766
12,515
13,338
14,597
15,348
15,019
15,563
14,641
9,452
8,692
1,677
1,243
1,110
1,110
753
497
99
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,692
0
8,692
8,692
8,692
0
0

8,692

497

753

1,110

1,243

1,677

8,692

9,452

14,641

15,563

15,019

15,348

14,597

13,338

12,515

12,766

12,155

11,089

10,858

6,637

8,932

7,435

7,124

6,637

5,025

6,027

7,718

6,577

5,990

7,624

11,753

10,900

10,700

7,300

Net Receivables

0
0
0
3,100
2,000
5,400
4,300
4,000
3,600
2,200
2,100
3,500
1,874
3,366
1,656
2,961
2,948
2,899
1,596
2,141
3,969
2,338
5,122
2,141
6,550
5,302
2,552
5,479
3,418
3,790
5,373
3,392
4,559
4,553
6,404
5,495
7,272
9,072
7,993
9,904
9,904
9,839
11,565
8,029
10,791
9,803
10,194
6,531
9,594
8,082
9,494
5,214
8,113
9,227
10,226
9,172
14,080
12,387
12,650
12,100
13,577
13,222
15,182
12,277
15,930
16,507
13,834
11,308
12,283
13,784
11,080
9,216
13,730
12,504
14,720
9,965
17,438
13,638
14,127
10,878
15,471
15,954
14,932
13,718
14,374
12,402
17,545
11,922
16,205
15,954
15,864
11,708
20,754
20,154
20,099
15,158
14,440
14,310
16,357
14,480
16,003
13,501
15,764
14,461
14,220
12,103
14,808
12,623

12,623

14,808

12,103

14,220

14,461

15,764

13,501

16,003

14,480

16,357

14,310

14,440

15,158

20,099

20,154

20,754

11,708

15,864

15,954

16,205

11,922

17,545

12,402

14,374

13,718

14,932

15,954

15,471

10,878

14,127

13,638

17,438

9,965

14,720

12,504

13,730

9,216

11,080

13,784

12,283

11,308

13,834

16,507

15,930

12,277

15,182

13,222

13,577

12,100

12,650

12,387

14,080

9,172

10,226

9,227

8,113

5,214

9,494

8,082

9,594

6,531

10,194

9,803

10,791

8,029

11,565

9,839

9,904

7,993

9,072

7,272

5,495

6,404

4,553

4,559

3,392

5,373

3,790

3,418

5,479

2,552

5,302

6,550

2,141

5,122

2,338

3,969

2,141

1,596

2,899

2,948

2,961

1,656

3,366

1,874

3,500

2,100

2,200

3,600

4,000

4,300

5,400

2,000

3,100

Other Current Assets

0
0
0
14,100
16,300
13,200
12,600
8,400
9,200
1,900
800
300
1,432
896
1,553
493
561
56
1,300
497
190
2,019
456
1,937
9
60
1,732
984
1,119
1,185
1,169
1,822
337
1,579
1,006
2,427
111
1,491
1,049
1,107
1,106
1,671
996
1,117
1,306
1,170
1,083
1,383
1,001
2,533
2,370
1,173
2,852
3,050
2,944
1,115
2,785
3,994
2,754
1,955
3,810
3,834
2,243
3,252
379
342
417
3,074
3,539
347
3,059
3,930
234
305
287
4,001
45
126
2,912
3,166
11
23
65
3,808
96
125
278
3,149
421
218
2,348
3,932
4,164
1,763
5,412
4,264
943
4,380
1,018
4,866
1,151
1,198
1,356
4,229
7,228
834
369
5,084

5,084

369

834

7,228

4,229

1,356

1,198

1,151

4,866

1,018

4,380

943

4,264

5,412

1,763

4,164

3,932

2,348

218

421

3,149

278

125

3,808

3,166

2,912

126

4,001

287

305

234

3,930

3,059

347

3,539

3,074

417

342

379

3,252

2,243

3,834

3,810

1,955

2,754

3,994

2,785

1,115

2,944

3,050

2,852

1,173

2,370

2,533

1,001

1,383

1,083

1,170

1,306

1,117

996

1,671

1,106

1,107

1,049

1,491

111

2,427

1,006

1,579

337

1,822

1,169

1,185

1,119

984

1,732

1,937

456

2,019

190

497

1,300

561

493

1,553

896

1,432

300

800

1,900

9,200

8,400

12,600

13,200

16,300

14,100

> Long-term Assets

0
0
0
700
900
5,400
6,400
9,000
10,900
11,400
12,500
13,500
15,137
16,396
18,212
18,388
17,998
21,952
21,901
0
21,202
21,137
21,093
21,480
22,352
22,350
22,163
22,152
22,758
22,783
22,544
22,500
22,302
22,075
26,138
26,457
26,352
48,932
48,594
0
48,535
48,907
48,924
49,268
48,611
48,888
48,810
61,706
60,627
61,245
61,082
60,835
60,158
59,311
77,035
78,429
77,822
79,453
79,325
78,539
78,119
77,370
76,978
76,231
75,633
75,234
75,006
74,522
74,002
74,393
73,861
76,322
75,281
75,277
73,409
72,988
73,556
73,758
73,384
73,559
73,676
73,593
74,918
75,057
78,698
79,252
79,947
79,622
81,698
81,387
81,079
81,528
80,916
80,084
79,880
79,311
84,643
84,260
83,460
83,833
84,233
84,453
85,878
86,745
89,134
92,640
95,393
98,077

98,077

95,393

92,640

89,134

86,745

85,878

84,453

84,233

83,833

83,460

84,260

84,643

79,311

79,880

80,084

80,916

81,528

81,079

81,387

81,698

79,622

79,947

79,252

78,698

75,057

74,918

73,593

73,676

73,559

73,384

73,758

73,556

72,988

73,409

75,277

75,281

76,322

73,861

74,393

74,002

74,522

75,006

75,234

75,633

76,231

76,978

77,370

78,119

78,539

79,325

79,453

77,822

78,429

77,035

59,311

60,158

60,835

61,082

61,245

60,627

61,706

48,810

48,888

48,611

49,268

48,924

48,907

48,535

48,594

48,932

26,352

26,457

26,138

22,075

22,302

22,500

22,544

22,783

22,758

22,152

22,163

22,350

22,352

21,480

21,093

21,137

21,202

21,901

21,952

17,998

18,388

18,212

16,396

15,137

13,500

12,500

11,400

10,900

9,000

6,400

5,400

900

700

Property Plant Equipment

0
0
0
500
700
1,300
1,700
2,300
4,300
5,000
6,100
7,500
9,354
10,761
12,677
13,218
12,941
13,016
13,137
12,907
12,661
12,628
12,553
12,907
12,419
12,398
12,250
12,189
12,827
12,887
12,669
12,355
12,176
11,992
11,884
11,891
11,860
11,949
11,807
11,716
11,716
11,634
11,523
11,974
12,231
12,385
12,595
13,747
13,693
14,403
14,233
13,975
13,503
13,031
14,372
14,482
14,227
13,804
13,888
13,613
13,511
13,124
12,907
12,493
12,192
12,089
12,040
11,898
11,725
12,179
11,943
12,143
11,604
11,743
11,161
11,125
11,631
11,843
11,659
11,806
12,133
12,138
12,089
12,359
12,456
13,320
14,269
14,153
16,108
15,857
13,696
13,530
12,655
13,667
12,267
11,726
12,845
11,525
12,506
12,391
13,767
14,389
16,422
17,248
19,486
22,953
26,752
30,265

30,265

26,752

22,953

19,486

17,248

16,422

14,389

13,767

12,391

12,506

11,525

12,845

11,726

12,267

13,667

12,655

13,530

13,696

15,857

16,108

14,153

14,269

13,320

12,456

12,359

12,089

12,138

12,133

11,806

11,659

11,843

11,631

11,125

11,161

11,743

11,604

12,143

11,943

12,179

11,725

11,898

12,040

12,089

12,192

12,493

12,907

13,124

13,511

13,613

13,888

13,804

14,227

14,482

14,372

13,031

13,503

13,975

14,233

14,403

13,693

13,747

12,595

12,385

12,231

11,974

11,523

11,634

11,716

11,807

11,949

11,860

11,891

11,884

11,992

12,176

12,355

12,669

12,887

12,827

12,189

12,250

12,398

12,419

12,907

12,553

12,628

12,661

12,907

13,137

13,016

12,941

13,218

12,677

10,761

9,354

7,500

6,100

5,000

4,300

2,300

1,700

1,300

700

500

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,908
0
0
7,889
9,080
9,110
9,109
8,002
8,997
8,997
8,997
8,293,346
8,277,784
8,262,414
11,900,902
11,483,401
11,481
30,044
30,055
30,014
30,014
30,751
31,017
31,051
30,927
30,962
30,882
39,276
38,543
38,739
38,982
39,924
40,010
39,927
53,139
55,133
55,170
57,589
57,693
57,730
57,798
57,715
57,839
57,799
57,736
57,638
57,698
57,592
57,499
57,599
57,475
58,489
58,280
58,336
57,867
57,792
57,944
57,946
57,913
57,861
57,881
57,942
58,036
58,021
57,956
57,913
57,955
57,831
57,877
57,922
57,896
57,935
57,746
57,829
57,875
57,255
61,614
61,640
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614

61,614

61,640

61,614

57,255

57,875

57,829

57,746

57,935

57,896

57,922

57,877

57,831

57,955

57,913

57,956

58,021

58,036

57,942

57,881

57,861

57,913

57,946

57,944

57,792

57,867

58,336

58,280

58,489

57,475

57,599

57,499

57,592

57,698

57,638

57,736

57,799

57,839

57,715

57,798

57,730

57,693

57,589

55,170

55,133

53,139

39,927

40,010

39,924

38,982

38,739

38,543

39,276

30,882

30,962

30,927

31,051

31,017

30,751

30,014

30,055

30,044

11,481

11,483,401

11,900,902

8,262,414

8,277,784

8,293,346

8,997

8,002

9,109

9,110

9,080

7,889

7,908

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
0
0
0
1,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,300

Intangible Assets

0
0
0
0
0
2,800
3,300
6,200
6,100
6,000
5,900
5,400
5,358
5,192
5,110
5,058
4,984
8,906
8,720
8,539
8,539
8,478
8,511
8,539
9,886
9,110
9,110
9,940
9,909
9,875
9,856
10,126
10,079
10,033
14,206
14,527
2,976
6,891
6,684
6,474
6,474
6,043
5,831
5,616
5,406
5,484
5,272
8,056
7,746
7,459
7,171
6,883
6,595
6,307
9,467
8,638
8,239
7,848
7,460
7,073
6,685
6,335
6,063
5,794
5,528
5,274
5,050
4,840
4,630
4,419
4,209
5,457
5,194
4,932
3,969
3,778
3,592
3,418
3,271
3,124
2,977
2,830
2,932
2,764
2,596
2,428
2,260
2,102
2,008
1,915
1,822
1,728
1,635
1,541
1,462
1,410
2,024
1,937
1,851
1,790
1,743
1,696
1,650
1,611
1,576
1,541
1,506
1,471

1,471

1,506

1,541

1,576

1,611

1,650

1,696

1,743

1,790

1,851

1,937

2,024

1,410

1,462

1,541

1,635

1,728

1,822

1,915

2,008

2,102

2,260

2,428

2,596

2,764

2,932

2,830

2,977

3,124

3,271

3,418

3,592

3,778

3,969

4,932

5,194

5,457

4,209

4,419

4,630

4,840

5,050

5,274

5,528

5,794

6,063

6,335

6,685

7,073

7,460

7,848

8,239

8,638

9,467

6,307

6,595

6,883

7,171

7,459

7,746

8,056

5,272

5,484

5,406

5,616

5,831

6,043

6,474

6,684

6,891

2,976

14,527

14,206

10,033

10,079

10,126

9,856

9,875

9,909

9,940

9,110

9,886

8,539

8,511

8,478

8,539

8,720

8,906

4,984

5,058

5,110

5,192

5,358

5,400

5,900

6,000

6,100

6,200

3,300

2,800

Other Assets

0
0
0
0
0
0
0
0
0
0
0
0
5,783
5,635
5,535
5,169
5,057
8,935
8,764
8,573
8,541
8,509
8,540
8,538
9,934
9,952
9,912
9,963
9,931
9,896
9,876
10,144
10,126
10,082
14,255
14,566
14,492
36,984
36,786
36,819
36,906
37,273
37,401
37,295
36,380
36,502
36,215
47,959
46,934
46,842
46,797
46,860
46,655
46,430
62,651
63,947
63,595
65,649
65,437
64,926
64,608
64,246
64,071
63,738
63,441
63,145
62,966
62,624
62,277
62,214
61,918
64,179
63,677
63,534
62,248
61,863
61,925
61,915
61,725
61,753
61,543
61,455
62,829
62,698
5,690
5,591
5,463
4,236
5,705
5,693
5,860
5,407
7,420
7,047
7,063
8,920
11,496
11,095
10,399
9,828
7,109
9,237
8,503
5,716
6,008
0
0
0

6,008

5,716

8,503

9,237

7,109

9,828

10,399

11,095

11,496

8,920

7,063

7,047

7,420

5,407

5,860

5,693

5,705

4,236

5,463

5,591

5,690

62,698

62,829

61,455

61,543

61,753

61,725

61,915

61,925

61,863

62,248

63,534

63,677

64,179

61,918

62,214

62,277

62,624

62,966

63,145

63,441

63,738

64,071

64,246

64,608

64,926

65,437

65,649

63,595

63,947

62,651

46,430

46,655

46,860

46,797

46,842

46,934

47,959

36,215

36,502

36,380

37,295

37,401

37,273

36,906

36,819

36,786

36,984

14,492

14,566

14,255

10,082

10,126

10,144

9,876

9,896

9,931

9,963

9,912

9,952

9,934

8,538

8,540

8,509

8,541

8,573

8,764

8,935

5,057

5,169

5,535

5,635

5,783

> Total Liabilities

0
0
0
4,500
4,400
8,100
6,300
8,900
8,500
7,800
9,100
10,700
11,461
12,248
11,682
10,255
9,922
11,051
10,182
10,419
10,494
11,050
10,738
10,419
12,865
13,255
12,152
13,249
13,731
13,809
12,586
12,936
13,696
15,851
15,081
12,082
10,372
26,674
23,942
24,781
24,781
23,842
22,427
19,582
24,826
22,768
21,156
33,546
33,140
30,964
31,835
28,328
31,280
32,456
45,718
47,186
46,867
47,754
47,442
45,122
44,971
44,531
45,360
43,304
43,555
41,664
42,376
39,241
38,958
39,790
40,755
41,762
40,609
41,353
42,886
54,877
42,200
36,841
38,076
37,818
40,487
36,746
39,896
37,275
35,612
76,068
78,578
88,601
81,832
78,308
78,674
77,793
78,558
71,207
70,517
69,108
73,628
75,484
73,058
72,203
71,668
67,609
67,217
58,428
59,641
55,877
62,264
73,482

73,482

62,264

55,877

59,641

58,428

67,217

67,609

71,668

72,203

73,058

75,484

73,628

69,108

70,517

71,207

78,558

77,793

78,674

78,308

81,832

88,601

78,578

76,068

35,612

37,275

39,896

36,746

40,487

37,818

38,076

36,841

42,200

54,877

42,886

41,353

40,609

41,762

40,755

39,790

38,958

39,241

42,376

41,664

43,555

43,304

45,360

44,531

44,971

45,122

47,442

47,754

46,867

47,186

45,718

32,456

31,280

28,328

31,835

30,964

33,140

33,546

21,156

22,768

24,826

19,582

22,427

23,842

24,781

23,942

26,674

10,372

12,082

15,081

15,851

13,696

12,936

12,586

13,809

13,731

13,249

12,152

13,255

12,865

10,419

10,738

11,050

10,494

10,419

10,182

11,051

9,922

10,255

11,682

12,248

11,461

10,700

9,100

7,800

8,500

8,900

6,300

8,100

4,400

4,500

> Total Current Liabilities

0
0
0
4,200
4,100
7,400
5,600
8,300
8,100
7,400
8,700
10,600
11,370
12,156
6,271
4,908
4,608
5,804
4,963
5,032
5,042
5,584
5,247
5,032
6,630
6,953
5,813
6,704
7,304
7,433
6,112
6,020
6,834
9,032
8,284
10,160
8,514
16,733
14,427
14,479
14,479
14,801
15,439
14,984
22,179
20,616
18,818
21,089
21,052
19,040
19,240
16,095
19,408
20,739
25,263
26,150
25,727
27,147
26,656
24,399
24,417
25,272
37,687
35,298
35,748
24,742
26,127
23,690
23,938
25,287
26,987
27,926
27,594
29,282
31,584
44,171
32,518
29,270
31,131
31,514
34,351
30,851
34,167
32,310
29,484
32,917
35,437
46,761
39,238
37,076
38,312
38,155
39,879
32,268
32,073
31,681
36,938
39,979
39,170
40,388
41,569
39,587
41,084
33,417
36,112
33,736
40,805
36,203

36,203

40,805

33,736

36,112

33,417

41,084

39,587

41,569

40,388

39,170

39,979

36,938

31,681

32,073

32,268

39,879

38,155

38,312

37,076

39,238

46,761

35,437

32,917

29,484

32,310

34,167

30,851

34,351

31,514

31,131

29,270

32,518

44,171

31,584

29,282

27,594

27,926

26,987

25,287

23,938

23,690

26,127

24,742

35,748

35,298

37,687

25,272

24,417

24,399

26,656

27,147

25,727

26,150

25,263

20,739

19,408

16,095

19,240

19,040

21,052

21,089

18,818

20,616

22,179

14,984

15,439

14,801

14,479

14,427

16,733

8,514

10,160

8,284

9,032

6,834

6,020

6,112

7,433

7,304

6,704

5,813

6,953

6,630

5,032

5,247

5,584

5,042

5,032

4,963

5,804

4,608

4,908

6,271

12,156

11,370

10,600

8,700

7,400

8,100

8,300

5,600

7,400

4,100

4,200

Short-term Debt

0
0
0
0
0
0
0
0
1,500
0
2,000
3,600
4,058
5,715
392
135
135
131
127
132
128
128
128
132
133
136
139
142
146
149
153
156
159
162
166
1,471
200
4,339
3,001
3,110
3,110
686
1,036
1,093
6,266
3,256
239
4,581
2,821
820
765
816
808
819
1,809
1,827
1,843
3,260
1,878
1,861
2,072
2,093
13,076
12,436
12,215
2,511
2,348
2,256
2,273
2,465
2,310
2,328
2,467
2,477
2,462
2,402
2,488
2,522
2,460
2,683
2,600
2,209
1,780
1,067
53
3,662
3,825
3,667
5,464
4,890
4,133
4,378
4,631
3,966
4,008
4,061
4,113
4,168
4,223
4,278
4,333
4,390
4,434
4,491
4,546
4,606
9,665
7,817

7,817

9,665

4,606

4,546

4,491

4,434

4,390

4,333

4,278

4,223

4,168

4,113

4,061

4,008

3,966

4,631

4,378

4,133

4,890

5,464

3,667

3,825

3,662

1,067

1,780

2,209

2,600

2,683

2,460

2,522

2,488

2,402

2,462

2,477

2,467

2,328

2,310

2,465

2,273

2,256

2,348

2,511

12,215

12,436

13,076

2,093

2,072

1,861

1,878

3,260

1,843

1,827

1,809

819

808

816

765

820

2,821

4,581

239

3,256

6,266

1,093

1,036

686

3,110

3,001

4,339

200

1,471

166

162

159

156

153

149

146

142

139

136

133

132

128

132

127

131

135

392

5,715

4,058

3,600

2,000

1,500

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,328
0
0
0
2,402
0
0
0
2,683
2,825
2,209
1,693
1,067
53
3,575
3,623
3,667
5,464
4,890
4,133
4,378
4,631
3,966
4,008
4,061
4,113
4,168
4,223
4,278
4,333
4,390
4,434
4,491
4,546
4,606
9,665
7,214

7,214

9,665

4,606

4,546

4,491

4,434

4,390

4,333

4,278

4,223

4,168

4,113

4,061

4,008

3,966

4,631

4,378

4,133

4,890

5,464

3,667

3,623

3,575

1,067

1,693

2,209

2,825

2,683

2,402

2,328

Accounts payable

0
0
0
600
900
1,800
1,300
700
1,700
2,000
2,600
1,700
2,552
1,815
2,434
1,771
1,388
1,479
1,559
1,391
1,312
560
401
1,391
591
640
659
548
954
702
617
430
654
872
803
1,066
6,404
10,423
8,340
1,153
9,416
12,117
11,254
11,028
13,222
14,545
1,041
863
1,181
1,056
1,025
598
2,447
564
1,087
956
703
870
1,316
783
2,909
2,725
503
2,658
1,298
1,146
818
654
674
923
3,498
6,028
721
1,358
1,221
21,834
1,572
732
3,918
3,916
817
883
548
3,546
724
1,362
839
3,651
1,530
1,186
4,281
4,913
4,947
957
3,341
1,095
1,027
4,959
961
7,393
1,134
1,658
1,056
5,136
5,193
2,152
1,424
1,301

1,301

1,424

2,152

5,193

5,136

1,056

1,658

1,134

7,393

961

4,959

1,027

1,095

3,341

957

4,947

4,913

4,281

1,186

1,530

3,651

839

1,362

724

3,546

548

883

817

3,916

3,918

732

1,572

21,834

1,221

1,358

721

6,028

3,498

923

674

654

818

1,146

1,298

2,658

503

2,725

2,909

783

1,316

870

703

956

1,087

564

2,447

598

1,025

1,056

1,181

863

1,041

14,545

13,222

11,028

11,254

12,117

9,416

1,153

8,340

10,423

6,404

1,066

803

872

654

430

617

702

954

548

659

640

591

1,391

401

560

1,312

1,391

1,559

1,479

1,388

1,771

2,434

1,815

2,552

1,700

2,600

2,000

1,700

700

1,300

1,800

900

600

Other Current Liabilities

0
0
0
3,600
3,200
5,600
4,300
7,600
4,900
5,400
4,100
5,300
4,759
4,626
3,444
3,002
1,982
3,145
2,300
3,509
1,017
3,932
1,733
2,649
1,624
1,342
1,775
1,575
2,047
1,393
1,945
1,397
1,627
1,715
2,091
2,189
208
1,971
1,000
10,216
1,952
1,998
843
2,863
566
86
2,567
-99,776
13,644
2,961
2,912
2,774
2,014
3,447
3,635
5,666
4,422
5,057
5,039
5,255
3,075
3,041
6,581
4,392
6,694
5,322
6,445
6,895
6,251
5,837
4,196
4,475
8,923
8,475
10,447
5,092
10,581
9,916
7,344
9,418
13,745
11,024
13,353
10,819
11,742
11,233
12,131
23,199
14,003
14,012
10,765
12,216
11,190
11,070
7,396
10,940
14,184
14,004
16,678
11,504
19,409
18,043
18,221
8,592
10,477
12,150
13,478
12,251

12,251

13,478

12,150

10,477

8,592

18,221

18,043

19,409

11,504

16,678

14,004

14,184

10,940

7,396

11,070

11,190

12,216

10,765

14,012

14,003

23,199

12,131

11,233

11,742

10,819

13,353

11,024

13,745

9,418

7,344

9,916

10,581

5,092

10,447

8,475

8,923

4,475

4,196

5,837

6,251

6,895

6,445

5,322

6,694

4,392

6,581

3,041

3,075

5,255

5,039

5,057

4,422

5,666

3,635

3,447

2,014

2,774

2,912

2,961

13,644

-99,776

2,567

566

2,863

843

1,998

1,952

10,216

1,000

1,971

208

2,189

2,091

1,715

1,627

1,397

1,945

1,393

2,047

1,575

1,775

1,342

1,624

2,649

1,733

3,932

1,017

3,509

2,300

3,145

1,982

3,002

3,444

4,626

4,759

5,300

4,100

5,400

4,900

7,600

4,300

5,600

3,200

3,600

> Long-term Liabilities

0
0
0
300
300
700
700
600
400
400
400
100
91
92
5,411
5,347
5,314
5,247
5,219
0
5,452
5,466
5,491
5,387
6,235
6,303
6,339
6,545
6,427
6,376
6,474
6,917
6,862
6,820
6,797
1,922
1,858
9,942
9,514
0
10,303
9,041
6,988
4,598
2,647
2,153
2,339
12,457
12,088
11,924
12,595
12,233
11,872
11,717
20,455
21,036
21,140
20,607
20,786
20,723
20,554
19,259
7,673
8,006
7,807
16,922
16,249
15,551
15,020
14,503
13,768
13,836
13,015
12,071
11,302
10,706
9,682
7,571
6,945
6,304
6,136
5,895
5,729
4,965
6,128
43,151
43,141
41,840
42,594
41,232
40,362
39,638
38,679
38,939
38,444
37,427
36,690
35,505
33,888
31,815
30,099
28,022
26,133
25,011
23,529
22,141
21,459
37,279

37,279

21,459

22,141

23,529

25,011

26,133

28,022

30,099

31,815

33,888

35,505

36,690

37,427

38,444

38,939

38,679

39,638

40,362

41,232

42,594

41,840

43,141

43,151

6,128

4,965

5,729

5,895

6,136

6,304

6,945

7,571

9,682

10,706

11,302

12,071

13,015

13,836

13,768

14,503

15,020

15,551

16,249

16,922

7,807

8,006

7,673

19,259

20,554

20,723

20,786

20,607

21,140

21,036

20,455

11,717

11,872

12,233

12,595

11,924

12,088

12,457

2,339

2,153

2,647

4,598

6,988

9,041

10,303

9,514

9,942

1,858

1,922

6,797

6,820

6,862

6,917

6,474

6,376

6,427

6,545

6,339

6,303

6,235

5,387

5,491

5,466

5,452

5,219

5,247

5,314

5,347

5,411

100

400

600

700

300

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,392
12,916
0
0
0
0
225
0
9,203
8,638
8,176
7,568
6,912
6,328
5,740
5,146
0
3,945
3,337
2,724
0
0
857
225
0
0
0
0
0
0
34,176
33,840
32,794
31,606
30,354
28,593
28,627
0
0
25,494
0
23,360
22,269
0
20,044
0
17,690
16,530
15,358
0
0

15,358

16,530

17,690

20,044

22,269

23,360

25,494

28,627

28,593

30,354

31,606

32,794

33,840

34,176

225

857

2,724

3,337

3,945

5,146

5,740

6,328

6,912

7,568

8,176

8,638

9,203

225

12,916

13,392

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
79
79
79
51
51
12
12
0
0
0
0
0
408
446
443
464
459
447
473
344
341
338
355
0
0
0
0
52
274
589
706
0
0
0
0
0
0
0
0
204
216
262
208
183
563
514
512
185
672
627
579
254
603
512
434
243
202
594
535
497
598
584
546
472
438
546
559
476
838
838
874
848
6,128
7,122
8,032
7,664
7,265
7,077
7,508
8,145
8,570
8,488
8,330
10,880
11,196
11,071
10,528
9,546
0
7,978
7,296
6,949
6,999
0
0
0

6,999

6,949

7,296

7,978

9,546

10,528

11,071

11,196

10,880

8,330

8,488

8,570

8,145

7,508

7,077

7,265

7,664

8,032

7,122

6,128

848

874

838

476

559

546

438

472

546

584

598

497

535

594

202

243

434

512

603

254

579

627

672

185

512

514

563

183

208

262

216

204

706

589

274

355

338

341

344

473

447

459

464

443

446

408

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,935
7,565
0
0
0
0
7,781
7,609
7,551
7,473
7,375
7,452
7,160
7,028
7,555
63
6,983
24
6,798
6,520
0
0
0
0
0
4,855
0
5,153
3,369
3,371
3,484
3,642
3,743
3,993
4,204
7,704
4,582
4,542
4,555
7,405
4,642
7,151
3,772
6,507
3,167
2,784
5,274
4,894
0
0
0

4,894

5,274

2,784

3,167

6,507

3,772

7,151

4,642

7,405

4,555

4,542

4,582

7,704

4,204

3,993

3,743

3,642

3,484

3,371

3,369

5,153

4,855

6,520

6,798

6,983

7,555

7,028

7,160

7,452

7,375

7,473

7,551

7,609

7,781

7,565

6,935

> Total Stockholder Equity

0
0
0
18,100
18,700
17,300
17,900
17,400
17,400
17,500
18,100
18,600
19,066
19,757
20,642
21,382
21,974
22,037
23,015
23,353
23,672
24,860
26,523
23,353
28,983
29,904
31,224
32,424
32,531
32,786
33,641
35,018
35,012
32,514
34,144
32,593
33,850
35,072
36,324
36,750
36,751
39,450
41,614
42,286
37,368
38,401
39,607
38,598
40,194
41,300
42,571
44,171
46,104
46,368
47,682
48,584
51,136
52,544
53,510
55,554
58,407
61,063
64,069
56,742
59,947
63,235
67,538
71,755
77,319
82,078
86,308
87,748
87,843
89,695
86,590
74,222
76,170
79,658
81,225
82,806
85,572
87,830
88,844
90,041
95,364
26,817
30,139
19,083
22,739
25,967
28,975
32,892
37,297
45,574
56,729
64,315
73,250
76,365
83,128
85,337
81,486
68,624
67,766
72,033
74,665
77,750
57,872
48,955

48,955

57,872

77,750

74,665

72,033

67,766

68,624

81,486

85,337

83,128

76,365

73,250

64,315

56,729

45,574

37,297

32,892

28,975

25,967

22,739

19,083

30,139

26,817

95,364

90,041

88,844

87,830

85,572

82,806

81,225

79,658

76,170

74,222

86,590

89,695

87,843

87,748

86,308

82,078

77,319

71,755

67,538

63,235

59,947

56,742

64,069

61,063

58,407

55,554

53,510

52,544

51,136

48,584

47,682

46,368

46,104

44,171

42,571

41,300

40,194

38,598

39,607

38,401

37,368

42,286

41,614

39,450

36,751

36,750

36,324

35,072

33,850

32,593

34,144

32,514

35,012

35,018

33,641

32,786

32,531

32,424

31,224

29,904

28,983

23,353

26,523

24,860

23,672

23,353

23,015

22,037

21,974

21,382

20,642

19,757

19,066

18,600

18,100

17,500

17,400

17,900

17,300

18,700

18,100

Common Stock

0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
7
7
7
7
7
7
8
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
29
29
29
29
29
29
29
29
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31

Retained Earnings Total Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,172
45,340
0
0
0
0
44,700
47,028
50,462
54,275
58,042
63,495
67,547
72,099
73,686
74,649
76,197
77,826
65,313
67,118
68,638
69,995
71,507
73,810
75,343
75,278
77,574
83,392
-99,810
-97,027
-106,339
-102,867
-100,201
-96,817
-93,357
-86,880
-79,165
-69,587
-61,375
-52,143
-49,304
-42,701
-36,112
-33,620
-31,242
-28,870
-25,184
-21,173
-16,849
0
0

-16,849

-21,173

-25,184

-28,870

-31,242

-33,620

-36,112

-42,701

-49,304

-52,143

-61,375

-69,587

-79,165

-86,880

-93,357

-96,817

-100,201

-102,867

-106,339

-97,027

-99,810

83,392

77,574

75,278

75,343

73,810

71,507

69,995

68,638

67,118

65,313

77,826

76,197

74,649

73,686

72,099

67,547

63,495

58,042

54,275

50,462

47,028

44,700

45,340

44,172

Accumulated Other Comprehensive Income

0
0
0
-500
-600
-700
-700
-800
-900
-1,000
-1,100
-1,200
-1,392
-1,666
-1,936
-14
12
5
17
-3,226
-24
12
25
-4
32
-374
-375
-421
-392
-483
-290
38
-238
-279
-238
-132
313
448
472
-10,940
359
674
907
932
765
813
694
-6
-97
253
571
769
953
766
894
1,108
1,333
1,294
797
907
1,117
848
1,267
1,124
889
505
746
302
-103
359
-231
-773
-1,827
-1,542
-2,570
-2,995
-2,121
-2,117
-2,315
-2,626
-2,508
-2,127
-1,528
-1,635
-2,049
-2,333
-2,053
-2,916
-2,551
-2,296
-2,442
-2,209
-3,333
-2,872
-2,623
-2,399
-2,343
-2,269
-2,377
-2,375
-2,324
-2,423
-2,608
-9,997
-9,997
-9,997
0
0

-9,997

-2,608

-2,423

-2,324

-2,375

-2,377

-2,269

-2,343

-2,399

-2,623

-2,872

-3,333

-2,209

-2,442

-2,296

-2,551

-2,916

-2,053

-2,333

-2,049

-1,635

-1,528

-2,127

-2,508

-2,626

-2,315

-2,117

-2,121

-2,995

-2,570

-1,542

-1,827

-773

-231

359

-103

302

746

505

889

1,124

1,267

848

1,117

907

797

1,294

1,333

1,108

894

766

953

769

571

253

-97

-6

694

813

765

932

907

674

359

-10,940

472

448

313

-132

-238

-279

-238

-290

-483

-392

-421

-375

-374

-4

-24

-3,226

-14

-1,936

-1,666

-1,392

-1,200

-1,100

-1,000

-900

-800

-700

-600

-500

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,059
30,630
0
0
0
0
39,514
40,832
41,049
41,298
42,192
43,614
43,859
44,127
44,864
45,370
45,745
43,335
44,103
43,519
45,645
46,345
46,725
48,787
49,620
50,121
51,025
52,216
155,614
156,384
157,312
158,247
158,691
160,524
162,154
165,631
167,808
170,052
171,785
172,642
172,844
173,112
173,942
174,227
174,561
175,162
175,453
176,057
176,646
0
0

176,646

176,057

175,453

175,162

174,561

174,227

173,942

173,112

172,844

172,642

171,785

170,052

167,808

165,631

162,154

160,524

158,691

158,247

157,312

156,384

155,614

52,216

51,025

50,121

49,620

48,787

46,725

46,345

45,645

43,519

44,103

43,335

45,745

45,370

44,864

44,127

43,859

43,614

42,192

41,298

41,049

40,832

39,514

30,630

30,059

Treasury Stock

-78,267

-75,949

-72,303

-56,828

-50,149

-44,937

-43,727

-41,144

-40,228

-38,151

-33,726

-32,320

-30,257

-30,120

-29,004

-27,195

-26,684

-38,225

-36,953

-35,057

-35,036

-34,547

-32,830

-32,538

-32,376

-32,229

-32,031

-30,735

-30,378

-30,058

-29,716

-28,810

-28,604

-26,147

-25,331

-25,214

-23,436

-23,265

-22,989

-22,919

-22,845

-22,682

-22,382

-22,377

-22,371

-22,365

-22,298

-19,614

-18,806

-18,717

-12,165

-12,105

-12,040

-11,976

-11,924

-11,698

-10,752

-10,688

-8,017

-5,050

-4,756

-4,703

-3,684

-3,067

-1,869

-1,645

-1,596

-1,522

-1,503

-1,491

Other Stockholders Equity

0
0
0
17,300
17,500
17,500
17,500
16,500
16,500
16,500
16,600
16,600
16,747
17,061
17,385
17,340
15,537
17,448
17,495
0
18,998
19,292
19,527
18,974
21,455
21,467
21,487
23,040
21,971
21,488
20,627
22,746
22,966
20,547
21,137
18,818
19,950
20,954
20,955
0
21,194
10,381
10,880
11,275
5,323
5,710
5,888
17,701
4,924
5,487
4,829
5,258
5,328
5,195
5,632
6,233
6,806
7,364
7,162
7,551
8,317
8,797
10,000
11,034
11,911
11,744
12,234
34,117
34,941
36,358
36,753
15,033
15,165
15,468
11,734
11,879
11,022
12,990
13,200
14,269
14,732
14,457
15,536
14,437
13,942
128,597
129,136
128,392
128,576
128,138
127,762
128,219
127,147
127,708
129,285
128,058
127,705
127,907
128,175
123,793
117,399
102,258
99,213
97,186
95,807
94,568
94,323
79,454

79,454

94,323

94,568

95,807

97,186

99,213

102,258

117,399

123,793

128,175

127,907

127,705

128,058

129,285

127,708

127,147

128,219

127,762

128,138

128,576

128,392

129,136

128,597

13,942

14,437

15,536

14,457

14,732

14,269

13,200

12,990

11,022

11,879

11,734

15,468

15,165

15,033

36,753

36,358

34,941

34,117

12,234

11,744

11,911

11,034

10,000

8,797

8,317

7,551

7,162

7,364

6,806

6,233

5,632

5,195

5,328

5,258

4,829

5,487

4,924

17,701

5,888

5,710

5,323

11,275

10,880

10,381

21,194

20,955

20,954

19,950

18,818

21,137

20,547

22,966

22,746

20,627

21,488

21,971

23,040

21,487

21,467

21,455

18,974

19,527

19,292

18,998

17,495

17,448

15,537

17,340

17,385

17,061

16,747

16,600

16,500

17,500

17,300

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31
Accounts Payable	1,301	5,136	7,393	1,095	4,913	3,651	3,546	3,916	21,834	6,028	654	2,658	2,302	956	598	863	11,028	9,416	1,066	430	548	1,391	1,391	1,771	1,700	700	600	500	-	-	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Other Comprehensive Income	0	0	-2,375	-2,399	-2,209	-2,916	-1,635	-2,626	-2,995	-773	302	1,124	907	1,108	769	-6	932	359	-132	38	-421	-4	-3,226	-14	-1,200	-800	-500	-400	-	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Lease Obligations	0	0	0	0	0	204	71	82	0	0	108	225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Stock	31	31	31	31	30	30	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Surpluse	0	175,453	173,942	171,785	162,154	157,312	51,025	46,725	44,103	44,864	42,192	39,514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash	6,653	25,026	54,361	34,690	13,517	12,991	34,733	33,021	42,145	40,042	22,092	8,286	8,082	3,519	2,512	1,109	3,355	876	844	3,648	3,441	1,080	1,080	3,219	1,100	4,900	4,700	2,800	-	-	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash And Short Term Investments	6,653	25,026	54,361	34,690	13,517	12,991	34,733	33,021	42,145	40,042	22,092	8,286	8,082	3,519	2,512	1,109	3,455	1,986	10,296	18,996	16,207	7,717	7,717	9,796	12,000	4,900	4,700	2,800	-	-	-
Common Stock	31	31	31	31	30	30	30	30	30	29	29	8	8	8	8	8	8	8	8	8	8	7	7	7	0	0	0	0	-	-	-
Common Stock Shares Outstanding	24,673	25,052	25,640	25,696	25,653	28,076	25,230	24,597	24,504	24,612	24,613	6,951	6,842	6,736	6,723	6,832	6,979	6,922	7,076	7,281	7,307	7,092	7,092	7,059	7,500	8,333	8,649	6,216	6,000	6,000	6,000
Common Stock Total Equity	0	31	31	31	30	30	30	30	30	29	29	8	8	8	8	8	8	8	8	8	8	8	7	7	0	0	0	0	-	-	-
Current Deferred Revenue	14,834	15,198	17,213	15,585	16,648	16,244	16,878	15,497	14,843	15,095	13,885	15,812	16,500	17,701	11,907	12,926	0	0	5,434	4,037	4,439	859	0	0	0	0	0	0	-	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Liab	0	5,274	3,772	4,555	4,204	3,484	0	0	6,798	7,555	7,375	7,781	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Good Will	61,614	61,614	61,614	57,255	57,935	57,831	58,021	57,861	57,792	58,489	57,592	57,799	57,730	55,133	39,924	39,276	31,051	30,014	11,483,401	8,293,346	8,002	7,889	0	0	0	0	0	0	-	-	-
Intangible Assets	1,471	1,611	1,790	1,410	1,728	2,102	2,764	3,124	3,778	5,457	4,840	5,794	7,073	8,638	6,883	8,056	5,616	6,474	14,527	10,126	9,940	8,539	8,539	5,058	5,400	6,200	0	0	-	-	-
Inventory	0	0	0	0	0	0	1,463	1,546	1,435	1,169	1,282	932	913	1,115	1,173	810	1,377	2,272	1,183	1,244	851	497	1,671	1,247	0	0	0	0	-	-	-
Liabilities And Stockholders Equity	122,437	130,461	157,540	133,423	110,685	107,684	127,316	120,624	129,099	129,510	110,996	100,046	100,676	95,616	72,499	70,648	61,869	61,532	44,675	47,954	45,673	33,772	33,772	31,637	29,300	26,300	22,600	6,200	4,996	3,539	1,368
Long Term Debt	29,470	17,690	22,269	26,547	29,795	34,176	87	857	3,337	5,740	8,068	225	12,950	14,660	6,903	8,374	1,901	7,983	0	4,745	4,901	5,044	5,170	5,296	0	0	0	0	-	-	-
Long Term Debt Total	0	17,690	22,269	0	30,354	34,176	0	857	3,337	5,740	8,176	225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Investments	0	0	0	0	1,300	1,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Debt	32,303	-2,845	-27,814	-4,082	20,656	-9,324	-33,666	-30,338	-39,743	-37,714	-19,836	4,150	-6,221	-1,692	-1,696	3,472	-362	10,217	627	1,253	1,602	4,222	4,222	2,212	2,500	-4,800	-4,700	-2,800	-	-	-
Net Invested Capital	85,639	94,214	111,884	94,923	67,065	56,926	91,108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Receivables	12,623	14,461	14,480	15,158	11,708	11,922	13,718	10,878	9,965	9,216	11,308	12,277	11,187	10,449	6,017	7,121	8,029	9,904	5,495	3,392	5,479	2,141	2,141	2,961	3,500	4,000	3,100	1,500	-	-	-
Net Tangible Assets	0	8,808	23,723	64,315	32,892	19,083	29,256	82,806	74,222	23,803	9,322	-6,851	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Working Capital	-11,843	10,299	33,319	22,431	-8,998	-18,699	19,949	15,551	11,940	25,262	12,784	-11,483	-2,262	-8,655	-4,432	-10,668	-2,384	-1,482	8,058	19,434	16,817	7,260	7,260	8,342	5,200	9,000	17,700	2,000	-	-	-
Non Current Assets Total	98,077	86,745	83,833	79,311	81,528	79,622	75,057	73,559	72,988	76,322	74,522	76,231	78,539	78,275	60,836	60,227	49,268	48,535	26,457	22,500	22,152	21,480	21,480	18,388	13,500	9,000	700	400	-	-	-
Non Current Liabilities Other	3,670	7,321	9,546	3,615	2,444	1,388	935	586	571	541	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Current Liabilities Total	37,279	25,011	31,815	37,427	39,638	41,840	4,965	6,304	10,706	13,836	15,551	8,006	20,723	21,036	12,233	10,961	4,598	10,303	1,922	6,917	6,545	5,387	5,387	5,347	100	600	300	300	-	-	-
Non Currrent Assets Other	4,727	7,869	9,828	10,330	10,063	7,638	4,677	3,892	4,071	5,690	5,032	5,939	7,196	63,793	46,861	46,575	37	331	39	18	23	34	34	111	600	500	200	100	-	-	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Assets	0	5,716	9,828	8,920	5,407	5,536	1,913	768	293	234	191	145	123	176	53	627	627	331	39	18	23	42	34	111	0	0	0	0	4,996	3,539	1,368
Other Current Assets	5,084	4,229	4,866	4,264	3,932	3,149	3,808	3,166	4,001	3,930	3,074	3,252	2,868	3,373	3,134	2,191	1,117	1,106	2,427	1,822	984	1,937	2,434	493	300	8,400	14,100	1,500	-	-	-
Other Current Liab	12,251	8,592	11,504	10,940	12,216	23,199	10,819	9,418	5,092	4,475	6,895	4,392	3,736	5,512	2,774	2,719	2,863	1,952	2,189	1,397	1,575	2,649	3,508	3,002	5,300	7,600	3,600	3,300	-	-	-
Other Liab	0	6,949	9,546	10,880	8,145	6,988	4,965	5,447	6,319	497	243	254	185	183	204	0	0	52	0	344	464	0	0	51	0	0	0	0	-	-	-
Other Stockholder Equity	79,454	97,186	123,793	128,058	128,428	128,308	14,437	14,269	11,879	15,033	34,117	11,034	7,551	6,233	5,258	17,701	11,275	21,194	18,818	22,746	23,040	18,974	18,974	17,340	16,600	16,500	17,300	400	1,830	1,623	290
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Property Plant And Equipment Gross	65,934	17,248	46,574	13,034	15,158	14,153	12,359	11,806	11,125	12,143	11,898	12,493	13,613	14,482	13,975	13,747	11,974	11,716	11,891	12,355	12,189	12,346	12,907	13,218	7,500	2,300	500	300	-	-	-
Property Plant And Equipment Net	30,265	17,248	12,391	11,726	13,530	14,153	12,359	11,806	11,125	12,143	11,898	12,493	13,613	14,482	13,975	13,652	11,974	11,716	11,891	12,355	12,189	12,907	12,907	13,218	7,500	2,300	500	300	-	-	-
Property Plant Equipment	0	17,248	12,391	11,726	13,530	14,153	12,359	11,806	11,125	12,143	11,898	12,493	13,613	14,482	13,975	13,747	11,974	11,716	11,891	12,356	12,189	12,346	12,907	13,218	0	0	0	0	-	-	-
Retained Earnings	-30,530	-25,184	-36,112	-61,375	-93,357	-106,339	77,574	71,507	65,313	73,686	58,042	44,700	46,995	41,343	37,905	33,677	30,004	26,488	23,360	20,382	15,831	7,597	7,597	5,927	3,200	1,700	1,300	2,100	-	-	-
Retained Earnings Total Equity	0	-25,184	-36,112	-61,375	-93,357	-106,339	77,574	71,507	65,313	73,686	58,042	44,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt	7,214	4,491	4,278	4,061	4,378	3,667	1,067	2,683	2,402	2,328	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt Total	38,956	22,181	26,547	30,608	34,173	3,667	1,067	2,683	2,402	2,328	2,256	12,436	1,861	1,827	816	4,581	2,993	11,093	1,471	4,901	5,043	5,302	5,302	5,430	3,600	100	0	0	-	-	-
Short Term Debt	7,817	4,491	4,278	4,061	4,378	3,667	1,067	2,683	2,402	2,328	2,256	12,436	1,861	1,827	816	4,581	1,093	3,110	1,471	156	142	132	132	135	3,600	0	0	0	-	-	-
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	99	1,110	9,452	15,348	12,766	6,637	6,637	6,577	10,900	0	0	0	-	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Assets	122,437	130,461	157,540	133,423	110,685	107,684	127,316	120,624	129,099	129,510	110,996	100,046	100,676	95,616	72,499	70,648	61,869	61,532	44,675	47,954	45,673	33,772	33,772	31,637	29,300	26,300	22,600	6,200	4,996	3,539	1,368
Total Current Assets	24,360	43,716	73,707	54,112	29,157	28,062	52,259	47,065	56,111	53,188	36,474	23,815	22,137	17,341	11,663	10,421	12,600	12,997	18,218	25,454	23,521	12,292	12,292	13,250	15,800	17,300	21,900	5,800	-	-	-
Total Current Liabilities	36,203	33,417	40,388	31,681	38,155	46,761	32,310	31,514	44,171	27,926	23,690	35,298	24,399	25,996	16,095	21,089	14,984	14,479	10,160	6,020	6,704	5,032	5,032	4,908	10,600	8,300	4,200	3,800	-	-	-
Total Liab	73,482	58,428	72,203	69,108	77,793	88,601	37,275	37,818	54,877	41,762	39,241	43,304	45,122	47,032	28,328	32,050	19,582	24,781	12,082	12,936	13,249	10,419	10,419	10,255	10,700	8,900	4,500	4,100	3,166	1,916	1,078
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Stockholder Equity	48,955	72,033	85,337	64,315	32,892	19,083	90,041	82,806	74,222	87,748	71,755	56,742	55,554	48,584	44,171	38,598	42,286	36,751	32,593	35,018	32,424	23,353	23,353	21,382	18,600	17,400	18,100	2,100	1,830	1,623	290
Treasury Stock	0	-78,267	-50,149	-43,727	-33,726	-29,004	-36,953	-32,830	-32,229	-30,058	-28,810	-28,604	-23,436	-22,845	-22,382	-22,298	-12,165	-11,924	-10,688	-4,756	-1,869	-1,596	-1,503	-1,503	0	0	0	0	-	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31
Accounts Payable	1,301	1,424	2,152	5,193	5,136	1,056	1,658	1,134	7,393	961	4,959	1,027	1,095	3,341	957	4,947	4,913	4,281	1,186	1,530	3,651	839	1,362	724	3,546	548	883	817	3,916	3,918	732	1,572	21,834	1,221	1,358	721	6,028	3,498	923	674	654	818	1,146	1,298	2,658	503	2,725	2,909	783	1,316	870	703	956	1,087	564	2,447	598	1,025	1,056	1,181	863	1,041	14,545	13,222	11,028	11,254	12,117	9,416	1,153	8,340	10,423	6,404	1,066	803	872	654	430	617	702	954	548	659	640	591	1,391	401	560	1,312	1,391	1,559	1,479	1,388	1,771	2,434	1,815	2,552	1,700	2,600	2,000	1,700	700	1,300	1,800	900	600	-	-	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Other Comprehensive Income	0	0	-9,997	-9,997	-9,997	-2,608	-2,423	-2,324	-2,375	-2,377	-2,269	-2,343	-2,399	-2,623	-2,872	-3,333	-2,209	-2,442	-2,296	-2,551	-2,916	-2,053	-2,333	-2,049	-1,635	-1,528	-2,127	-2,508	-2,626	-2,315	-2,117	-2,121	-2,995	-2,570	-1,542	-1,827	-773	-231	359	-103	302	746	505	889	1,124	1,267	848	1,117	907	797	1,294	1,333	1,108	894	766	953	769	571	253	-97	-6	694	813	765	932	907	674	359	-10,940	472	448	313	-132	-238	-279	-238	38	-290	-483	-392	-421	-375	-374	32	-4	25	12	-24	-3,226	17	5	12	-14	-1,936	-1,666	-1,392	-1,200	-1,100	-1,000	-900	-800	-700	-700	-600	-500	-	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76	108	0	0	0	225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Stock	31	31	31	31	31	31	31	31	31	31	31	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Surpluse	0	0	176,646	176,057	175,453	175,162	174,561	174,227	173,942	173,112	172,844	172,642	171,785	170,052	167,808	165,631	162,154	160,524	158,691	158,247	157,312	156,384	155,614	52,216	51,025	50,121	49,620	48,787	46,725	46,345	45,645	43,519	44,103	43,335	45,745	45,370	44,864	44,127	43,859	43,614	42,192	41,298	41,049	40,832	39,514	0	0	0	0	30,630	30,059	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash	6,653	3,828	22,496	23,724	25,026	28,392	32,974	47,290	54,361	52,482	48,899	43,454	34,690	21,855	11,957	10,021	13,517	8,358	4,020	2,641	12,991	7,273	6,698	35,478	34,733	35,750	31,628	34,664	33,021	28,878	27,192	25,366	42,145	37,580	40,555	37,010	40,042	39,063	31,539	26,453	22,092	18,934	10,802	9,234	8,286	15,026	11,168	7,872	8,082	6,223	4,464	3,316	3,519	3,195	7,236	6,261	2,512	1,460	404	620	1,109	677	1,309	1,486	3,355	2,059	2,122	876	876	1,387	575	1,031	844	1,036	3,125	5,326	3,648	2,543	3,942	5,226	3,441	3,947	2,698	1,257	1,080	1,658	1,870	1,233	1,080	2,924	1,137	2,673	3,219	4,912	3,724	330	1,100	1,100	2,500	2,200	4,900	900	1,400	3,900	4,700	-	-	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash And Short Term Investments	6,653	3,828	22,496	23,724	25,026	28,392	32,974	47,290	54,361	52,482	48,899	43,454	34,690	21,855	11,957	10,021	13,517	8,358	4,020	2,641	12,991	7,273	6,698	35,478	34,733	35,750	31,628	34,664	33,021	28,878	27,192	25,366	42,145	37,580	40,555	37,010	40,042	39,063	31,539	26,453	22,092	18,934	10,802	9,234	8,286	15,026	11,168	7,872	8,082	6,223	4,464	3,316	3,519	3,195	7,236	6,261	2,512	1,460	404	620	1,109	677	1,309	1,486	3,455	2,556	2,875	1,986	0	2,630	2,252	9,723	10,296	15,677	18,688	20,344	18,996	17,141	17,280	17,741	16,207	16,102	13,788	12,115	7,717	10,590	9,305	8,357	0	7,949	7,164	10,390	9,796	10,902	11,347	12,084	12,000	11,800	9,800	2,200	4,900	900	1,400	3,900	4,700	-	-	-
Common Stock	31	31	31	31	31	31	31	31	31	31	31	31	31	31	31	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	29	29	29	29	29	29	29	29	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	7	8	7	7	7	7	7	7	7	7	7	7	0	0	0	0	0	0	0	0	0	-	-	-
Common Stock Shares Outstanding	24,548	24,695	24,716	24,738	24,775	24,847	25,211	25,390	25,597	25,650	25,645	25,668	25,684	25,704	25,680	25,725	25,715	25,741	25,586	25,509	25,534	25,526	28,466	25,467	25,468	25,360	25,116	24,821	24,687	24,624	24,557	24,561	24,459	24,458	24,551	24,557	24,604	24,571	24,612	24,675	24,651	24,625	24,601	12,287	6,986	12,182	6,943	6,907	6,719	6,850	6,855	6,809	6,654	6,727	6,732	6,711	6,640	6,735	6,734	6,713	6,633	6,803	6,793	6,970	6,818	7,013	7,002	6,842	6,842	6,986	6,970	6,918	6,819	7,056	7,179	7,202	7,150	7,224	7,284	7,353	7,256	7,331	7,303	7,296	7,099	7,200	7,194	7,166	7,099	7,102	7,057	7,058	7,039	7,069	7,062	7,037	7,006	6,667	7,057	7,060	7,060	6,667	7,368	7,500	7,500	6,429	6,000	6,364
Common Stock Total Equity	0	0	31	31	31	31	31	31	31	31	31	31	31	31	31	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	29	29	29	29	29	29	29	29	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	7	7	7	7	7	7	7	7	7	7	0	0	0	0	0	0	0	0	0	-	-	-
Current Deferred Revenue	14,834	16,238	14,828	15,896	15,198	17,373	15,496	16,693	17,213	17,308	16,848	17,614	15,585	17,328	16,275	19,111	16,648	19,133	16,988	18,241	16,244	18,642	16,660	16,965	16,878	18,486	16,735	17,189	15,497	17,409	16,100	17,877	14,843	17,454	16,972	15,483	15,095	16,983	16,062	14,740	13,885	16,516	15,763	15,541	15,812	17,527	17,413	16,361	16,500	18,423	17,960	18,759	17,701	18,732	15,909	14,139	11,907	14,538	14,203	3,405	115,421	14,970	2,728	2,125	0	2,305	0	2,130	0	2,087	0	1,702	5,434	5,225	6,282	4,394	4,037	3,399	5,189	4,157	4,439	3,240	4,834	4,282	859	2,985	965	2,585	0	978	1,050	1,103	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Liab	0	0	0	4,894	5,274	2,784	3,167	6,507	3,772	7,151	4,642	7,405	4,555	4,542	4,582	7,704	4,204	3,993	3,743	3,642	3,484	3,371	3,369	5,153	0	4,855	0	0	0	0	0	6,520	6,798	24	6,983	63	7,555	7,028	7,160	7,452	7,375	7,473	7,551	7,609	7,781	0	0	0	0	7,565	6,935	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Good Will	61,614	61,614	61,614	61,614	61,614	61,614	61,614	61,614	61,614	61,614	61,640	61,614	57,255	57,875	57,829	57,746	57,935	57,896	57,922	57,877	57,831	57,955	57,913	57,956	58,021	58,036	57,942	57,881	57,861	57,913	57,946	57,944	57,792	57,867	58,336	58,280	58,489	57,475	57,599	57,499	57,592	57,698	57,638	57,736	57,799	57,839	57,715	57,798	57,730	57,693	57,589	55,170	55,133	53,139	39,927	40,010	39,924	38,982	38,739	38,543	39,276	30,882	30,962	30,927	31,051	31,017	30,751	30,014	30,014	30,055	30,044	11,481	11,483,401	11,900,902	8,262,414	8,277,784	8,293,346	8,997	8,997	8,997	8,002	9,109	9,110	9,080	7,889	0	0	7,908	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Intangible Assets	1,471	1,506	1,541	1,576	1,611	1,650	1,696	1,743	1,790	1,851	1,937	2,024	1,410	1,462	1,541	1,635	1,728	1,822	1,915	2,008	2,102	2,260	2,428	2,596	2,764	2,932	2,830	2,977	3,124	3,271	3,418	3,592	3,778	3,969	4,932	5,194	5,457	4,209	4,419	4,630	4,840	5,050	5,274	5,528	5,794	6,063	6,335	6,685	7,073	7,460	7,848	8,239	8,638	9,467	6,307	6,595	6,883	7,171	7,459	7,746	8,056	5,272	5,484	5,406	5,616	5,831	6,043	6,474	6,474	6,684	6,891	2,976	14,527	14,206	10,033	10,079	10,126	9,856	9,875	9,909	9,940	9,110	9,110	9,886	8,539	8,511	8,478	8,539	8,539	8,720	8,906	4,984	5,058	5,110	5,192	5,358	5,400	5,900	6,000	6,100	6,200	3,300	2,800	0	0	-	-	-
Inventory	0	5,738	5,554	0	0	3,593	4,107	4,477	0	2,869	0	3,398	0	0	2,823	0	0	0	2,696	3,606	0	3,674	4,408	2,330	1,463	3,075	3,378	2,237	1,546	1,301	1,785	1,965	1,435	3,480	2,407	2,197	1,169	1,130	1,805	1,263	1,282	1,723	2,014	2,326	932	886	1,502	999	913	975	1,985	1,155	3,535	693	1,248	1,131	2,765	729	1,154	1,492	1,415	697	1,164	1,309	1,377	1,429	2,058	1,368	2,272	2,087	2,627	765	1,183	1,440	1,470	1,165	1,244	1,287	1,557	1,226	851	827	1,659	822	497	2,284	1,112	448	1,671	451	1,017	1,226	1,247	1,299	1,066	874	0	0	0	0	0	0	0	0	0	-	-	-
Liabilities And Stockholders Equity	122,437	120,136	133,627	134,306	130,461	134,983	136,233	153,154	157,540	156,186	151,849	146,878	133,423	127,246	116,781	115,855	110,685	107,649	104,275	104,571	107,684	108,717	102,885	130,976	127,316	128,740	124,576	126,059	120,624	119,301	116,499	118,370	129,099	129,476	131,048	128,452	129,510	127,063	121,868	116,277	110,996	109,914	104,899	103,502	100,046	109,429	105,594	103,378	100,676	100,952	100,298	98,003	95,770	93,400	78,824	77,384	72,499	74,406	72,264	73,334	72,145	60,764	61,169	62,194	61,869	64,041	63,292	61,532	61,532	60,265	61,747	44,222	44,675	49,226	48,365	48,708	47,954	46,228	46,595	46,262	45,673	43,375	43,159	41,848	33,772	37,261	35,910	34,166	33,772	33,198	33,088	31,896	31,637	32,323	32,005	30,527	29,300	27,200	25,300	25,900	26,300	24,200	25,400	23,100	22,600	-	-	-
Long Term Debt	29,470	14,164	15,358	16,530	17,690	18,837	20,044	21,161	22,269	23,360	24,434	25,494	26,547	27,583	28,627	28,593	29,795	30,977	32,139	33,223	34,176	35,109	36,029	0	87	0	0	225	857	1,485	2,107	2,724	3,337	3,945	4,548	5,146	5,740	6,328	6,912	7,492	8,068	8,638	9,203	0	225	0	11,457	11,948	12,950	12,916	13,392	13,864	14,660	14,795	6,149	6,357	6,903	7,794	7,988	8,187	8,374	0	0	351	1,901	3,779	6,077	7,609	7,983	8,152	8,361	0	0	4,618	4,660	4,703	4,745	4,784	4,823	4,862	4,901	4,938	4,973	5,009	5,044	5,079	5,119	5,148	5,170	5,207	5,235	5,263	5,296	5,331	13	12	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Debt Total	0	0	15,358	16,530	17,690	0	20,044	0	22,269	23,360	0	25,494	0	0	28,627	28,593	30,354	31,606	32,794	33,840	34,176	0	0	0	0	0	0	225	857	0	0	2,724	3,337	3,945	0	5,146	5,740	6,328	6,912	7,568	8,176	8,638	9,203	0	225	0	0	0	0	12,916	13,392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,300	0	0	0	1,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Debt	32,303	20,001	-2,532	-2,648	-2,845	-5,121	-8,540	-21,796	-27,814	-24,899	-20,297	-13,847	-4,082	9,736	20,636	23,203	20,656	26,752	33,009	36,046	-9,324	31,661	32,993	-35,425	-33,666	-33,970	-29,419	-31,839	-30,338	-26,418	-22,563	-20,154	-39,743	-31,173	-33,530	-29,397	-37,714	-36,753	-22,162	-24,180	-19,836	-7,948	912	2,981	4,150	-1,950	-9,075	-5,800	6,729	-4,345	-1,204	12,391	12,641	-1,386	-6,417	-5,453	5,207	-695	416	10,388	11,845	-438	1,948	5,131	-362	2,756	4,641	10,217	10,217	1,614	12,125	-831	627	3,748	1,697	-464	1,253	2,394	1,031	-218	1,602	1,130	2,411	3,885	4,222	3,548	3,377	4,043	4,222	2,411	4,229	2,725	2,212	811	2,004	3,740	2,500	1,000	-2,400	-600	-4,800	-800	-1,300	-3,900	-4,700	-	-	-
Net Invested Capital	85,639	81,701	97,714	95,741	94,214	91,037	93,058	106,980	111,884	110,711	104,967	102,857	94,923	88,320	78,167	70,521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Receivables	12,623	14,808	12,103	14,220	14,461	15,764	13,501	16,003	14,480	16,357	14,310	14,440	15,158	20,099	20,154	20,754	11,708	15,864	15,954	16,205	11,922	17,545	12,402	14,374	13,718	14,932	15,954	15,471	10,878	14,127	13,638	17,438	9,965	14,720	12,504	13,730	9,216	11,080	13,784	12,283	11,308	13,834	16,507	15,930	12,277	15,182	13,222	13,577	12,100	12,650	12,387	14,080	9,172	10,226	9,227	8,113	5,214	9,494	8,082	9,594	6,531	10,194	9,803	10,791	8,029	11,565	9,839	9,904	9,904	7,993	9,072	7,272	5,495	6,404	4,553	4,559	3,392	5,373	3,790	3,418	5,479	2,552	5,302	6,550	2,141	5,122	2,338	3,969	2,141	1,596	2,899	2,948	2,961	1,656	3,366	1,874	3,500	2,100	2,200	3,600	4,000	4,300	5,400	2,000	3,100	-	-	-
Net Tangible Assets	0	0	77,750	11,475	8,808	67,766	7,010	81,486	23,723	21,514	14,725	9,612	64,315	-2,608	45,574	-22,084	32,892	28,975	-33,870	22,739	19,083	-27,816	26,817	34,812	29,256	27,876	87,830	85,572	82,806	81,225	79,658	14,634	74,222	24,754	89,695	24,369	23,803	24,624	20,060	15,190	9,322	4,790	323	-3,317	-6,851	0	0	0	0	-11,643	-12,893	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Working Capital	-11,843	-16,062	7,251	9,060	10,299	8,021	12,193	27,352	33,319	33,556	27,610	25,297	22,431	15,293	4,429	-4,940	-8,998	-11,742	-14,188	-16,365	-18,699	-6,667	-9,284	22,794	19,949	19,655	20,132	18,032	15,551	14,786	13,471	12,296	11,940	24,483	26,489	25,577	25,262	26,215	22,188	18,337	12,784	8,781	4,923	-7,879	-11,483	-5,236	2,952	842	-2,262	-5,029	-6,302	-5,546	-8,809	-8,898	-1,226	-2,182	-4,431	-5,916	-8,021	-8,345	-10,650	-6,864	-8,334	-8,596	-2,384	-322	-415	-1,482	-1,482	-2,756	-3,918	9,356	8,058	14,803	17,259	19,572	19,434	17,571	16,379	16,200	16,817	15,400	13,856	12,866	7,260	10,921	9,189	7,922	7,260	6,334	5,331	9,291	8,342	7,840	3,453	4,021	5,200	6,000	6,500	6,900	9,000	12,200	12,600	18,100	17,700	-	-	-
Non Current Assets Total	98,077	95,393	92,640	89,134	86,745	85,878	84,453	84,233	83,833	83,460	84,260	84,643	79,311	79,880	80,084	80,916	81,528	81,079	81,387	81,698	79,622	79,947	79,252	78,698	75,057	74,918	73,593	73,676	73,559	73,384	73,758	73,556	72,988	73,409	75,277	75,281	76,322	73,861	74,393	74,002	74,522	75,006	75,234	75,633	76,231	76,978	77,370	78,119	78,539	79,325	79,453	77,822	78,429	77,035	59,311	60,158	60,835	61,082	61,245	60,627	61,706	48,810	48,888	48,611	49,268	48,924	48,907	48,535	0	48,594	48,932	26,352	26,457	26,138	22,075	22,302	22,500	22,544	22,783	22,758	22,152	22,163	22,350	22,352	21,480	21,093	21,137	21,202	0	21,901	21,952	17,998	18,388	18,212	16,396	15,137	13,500	12,500	11,400	10,900	9,000	6,400	5,400	900	700	-	-	-
Non Current Liabilities Other	3,670	2,752	2,266	6,999	7,321	2,055	2,251	2,431	9,546	3,377	3,662	3,791	3,615	3,596	2,585	2,382	2,444	2,175	2,325	2,837	0	1,433	0	975	935	874	0	0	0	0	0	438	571	522	540	0	541	412	431	0	0	138	168	198	0	0	0	0	0	305	280	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Current Liabilities Total	37,279	21,459	22,141	23,529	25,011	26,133	28,022	30,099	31,815	33,888	35,505	36,690	37,427	38,444	38,939	38,679	39,638	40,362	41,232	42,594	41,840	43,141	43,151	6,128	4,965	5,729	5,895	6,136	6,304	6,945	7,571	9,682	10,706	11,302	12,071	13,015	13,836	13,768	14,503	15,020	15,551	16,249	16,922	7,807	8,006	7,673	19,259	20,554	20,723	20,786	20,607	21,140	21,036	20,455	11,717	11,872	12,233	12,595	11,924	12,088	12,457	2,339	2,153	2,647	4,598	6,988	9,041	10,303	0	9,514	9,942	1,858	1,922	6,797	6,820	6,862	6,917	6,474	6,376	6,427	6,545	6,339	6,303	6,235	5,387	5,491	5,466	5,452	0	5,219	5,247	5,314	5,347	5,411	92	91	100	400	400	400	600	700	700	300	300	-	-	-
Non Currrent Assets Other	4,727	3,876	4,580	8,023	7,869	6,175	6,736	7,092	9,828	3,252	11,095	3,327	10,330	9,738	2,465	10,515	10,063	9,487	1,950	2,063	7,638	2,092	2,222	2,119	4,677	1,861	683	685	3,892	3,812	551	389	4,071	412	266	203	5,690	4,443	196	4,778	5,032	218	233	177	5,939	169	6,531	6,810	123	65,437	65,649	186	176	62,663	46,280	46,655	53	46,849	46,842	644	627	60	56	47	37	49	50	331	331	48	49	36	39	49	50	47	18	20	21	22	23	803	842	47	34	30	31	633	34	35	23	24	111	425	443	424	600	500	400	500	500	1,400	1,300	200	200	-	-	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Assets	0	0	0	6,008	5,716	8,503	9,237	7,109	9,828	10,399	11,095	11,496	8,920	7,063	7,047	7,420	5,407	5,860	5,693	5,705	4,236	5,463	5,591	5,690	62,698	62,829	61,455	61,543	61,753	61,725	61,915	61,925	61,863	62,248	63,534	63,677	64,179	61,918	62,214	62,277	62,624	62,966	63,145	63,441	63,738	64,071	64,246	64,608	64,926	65,437	65,649	63,595	63,947	62,651	46,430	46,655	46,860	46,797	46,842	46,934	47,959	36,215	36,502	36,380	37,295	37,401	37,273	36,906	36,819	36,786	36,984	14,492	14,566	14,255	10,082	10,126	10,144	9,876	9,896	9,931	9,963	9,912	9,952	9,934	8,538	8,540	8,509	8,541	8,573	8,764	8,935	5,057	5,169	5,535	5,635	5,783	0	0	0	0	0	0	0	0	0	-	-	-
Other Current Assets	5,084	369	834	7,228	4,229	1,356	1,198	1,151	4,866	1,018	4,380	943	4,264	5,412	1,763	4,164	3,932	2,348	218	421	3,149	278	125	96	3,808	65	23	11	3,166	2,912	126	45	4,001	287	305	234	3,930	3,059	347	3,539	3,074	417	342	379	3,252	2,243	3,834	3,810	1,955	2,754	3,994	2,785	1,115	2,944	3,050	2,852	1,173	2,370	2,533	1,001	1,383	1,083	1,170	1,306	1,117	996	1,671	1,106	1,107	1,049	1,491	111	2,427	1,006	1,579	337	1,822	1,169	1,185	1,119	984	1,732	60	9	1,937	456	2,019	190	497	1,300	56	561	493	1,553	896	1,432	300	800	1,900	9,200	8,400	12,600	13,200	16,300	14,100	-	-	-
Other Current Liab	12,251	13,478	12,150	10,477	8,592	18,221	18,043	19,409	11,504	16,678	14,004	14,184	10,940	7,396	11,070	11,190	12,216	10,765	14,012	14,003	23,199	12,131	11,233	11,742	10,819	13,353	11,024	13,745	9,418	7,344	9,916	10,581	5,092	10,447	8,475	8,923	4,475	4,196	5,837	6,251	6,895	6,445	5,322	6,694	4,392	6,581	3,041	3,075	5,255	5,039	5,057	4,422	5,666	3,635	3,447	2,014	2,774	2,912	2,961	13,644	-99,776	2,567	86	566	2,863	843	1,998	1,952	10,216	1,000	1,971	208	2,189	2,091	1,715	1,627	1,397	1,945	1,393	2,047	1,575	1,775	1,342	1,624	2,649	1,733	3,932	1,017	3,509	2,300	3,145	1,982	3,002	3,444	4,626	4,759	5,300	4,100	5,400	4,900	7,600	4,300	5,600	3,200	3,600	-	-	-
Other Liab	0	0	0	6,999	6,949	7,296	7,978	0	9,546	10,528	11,071	11,196	10,880	8,330	8,488	8,570	8,145	7,508	7,077	7,265	7,664	8,032	7,122	6,128	848	874	838	838	476	559	546	438	472	546	584	598	497	535	594	202	243	434	512	603	254	579	627	672	185	512	514	563	183	208	262	216	204	0	0	0	0	0	0	0	0	706	589	274	52	0	0	0	0	355	338	341	344	473	447	459	464	443	446	408	0	0	0	0	0	12	12	51	51	79	79	79	0	0	0	0	0	0	0	0	0	-	-	-
Other Stockholder Equity	79,454	94,323	94,568	95,807	97,186	99,213	102,258	117,399	123,793	128,175	127,907	127,705	128,058	129,285	127,708	127,147	128,219	127,762	128,138	128,576	128,392	129,136	128,597	13,942	14,437	15,536	14,457	14,732	14,269	13,200	12,990	11,022	11,879	11,734	15,468	15,165	15,033	36,753	36,358	34,941	34,117	12,234	11,744	11,911	11,034	10,000	8,797	8,317	7,551	7,162	7,364	6,806	6,233	5,632	5,195	5,328	5,258	4,829	5,487	4,924	17,701	5,888	5,710	5,323	11,275	10,880	10,381	21,194	0	20,955	20,954	19,950	18,818	21,137	20,547	22,966	22,746	20,627	21,488	21,971	23,040	21,487	21,467	21,455	18,974	19,527	19,292	18,998	0	17,495	17,448	15,537	17,340	17,385	17,061	16,747	16,600	16,600	16,500	16,500	16,500	17,500	17,500	17,500	17,300	-	-	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Property Plant And Equipment Gross	65,934	63,929	22,609	54,802	17,248	52,843	0	12,853	0	0	12,659	12,845	13,034	13,480	13,667	14,115	15,158	15,501	15,857	16,108	14,153	14,269	13,320	12,456	12,359	12,089	12,138	12,133	11,806	11,659	11,843	11,631	11,125	11,161	11,743	11,604	12,143	11,943	12,179	11,725	11,898	12,040	12,089	12,192	12,493	12,907	13,124	13,511	13,613	13,888	13,804	14,227	14,482	14,372	13,031	13,503	13,975	14,233	14,403	13,693	13,747	12,595	12,385	12,231	11,974	11,523	11,634	11,716	11,716	11,807	11,949	11,860	11,891	11,884	11,992	12,176	12,355	12,669	12,887	12,827	12,189	12,250	12,398	12,419	12,346	12,553	12,628	12,907	12,907	13,137	13,016	12,941	13,218	12,677	10,761	9,354	7,500	6,100	5,000	4,300	2,300	1,700	1,300	700	500	-	-	-
Property Plant And Equipment Net	30,265	26,752	22,953	19,486	17,248	16,422	14,389	13,767	12,391	12,506	11,525	12,845	11,726	12,267	13,667	12,655	13,530	13,696	15,857	16,108	14,153	14,269	13,320	12,456	12,359	12,089	12,138	12,133	11,806	11,659	11,843	11,631	11,125	11,161	11,743	11,604	12,143	11,943	12,179	11,725	11,898	12,040	12,089	12,192	12,493	12,907	13,124	13,511	13,613	13,888	13,804	14,227	14,482	14,372	13,031	13,503	13,975	14,233	14,403	13,693	13,747	12,595	12,385	12,231	11,974	11,523	11,634	11,716	0	11,807	11,949	11,860	11,891	11,884	11,992	12,176	12,355	12,669	12,887	12,827	12,189	12,250	12,398	12,419	12,907	12,553	12,628	12,661	0	13,137	13,016	12,941	13,218	12,677	10,761	9,354	7,500	6,100	5,000	4,300	2,300	1,700	1,300	700	500	-	-	-
Property Plant Equipment	0	0	22,609	19,486	17,248	15,761	13,602	12,853	12,391	11,447	11,525	11,533	11,726	12,267	12,355	12,655	13,530	13,696	13,872	13,968	14,153	14,269	13,320	12,456	12,359	12,089	12,138	12,133	11,806	11,659	11,843	11,631	11,125	11,161	11,743	11,604	12,143	11,943	12,179	11,725	11,898	12,040	12,089	12,192	12,493	12,907	13,124	13,511	13,613	13,888	13,804	14,227	14,482	14,372	13,031	13,503	13,975	14,233	14,403	13,693	13,747	12,595	12,385	12,231	11,974	11,523	11,634	11,686	11,716	11,807	11,949	11,860	11,891	11,884	11,992	12,176	12,356	12,668	12,887	12,827	12,189	12,250	12,399	12,418	12,346	12,553	12,628	12,661	12,907	13,137	13,016	12,941	13,218	12,677	10,761	9,353	0	0	0	0	0	0	0	0	0	-	-	-
Retained Earnings	-30,530	-36,482	-16,849	-21,173	-25,184	-28,870	-31,242	-33,620	-36,112	-42,701	-49,304	-52,143	-61,375	-69,587	-79,165	-86,880	-93,357	-96,817	-100,201	-102,867	-106,339	-97,027	-99,810	83,392	77,574	75,278	75,343	73,810	71,507	69,995	68,638	67,118	65,313	77,826	76,197	74,649	73,686	72,099	67,547	63,495	58,042	54,275	50,462	47,028	44,700	53,061	51,258	49,082	46,995	45,340	44,172	43,322	41,343	41,042	40,165	39,768	37,905	36,734	35,805	35,262	33,677	32,712	31,683	31,037	30,004	29,726	28,061	26,488	26,488	26,172	24,518	23,890	23,360	22,374	20,905	20,555	20,382	19,462	17,745	17,007	15,831	14,576	13,276	12,368	7,597	10,214	8,787	7,892	7,597	7,405	6,473	6,430	5,927	5,186	4,354	3,704	3,200	2,600	2,000	1,800	1,700	1,100	500	1,800	1,300	-	-	-
Retained Earnings Total Equity	0	0	-16,849	-21,173	-25,184	-28,870	-31,242	-33,620	-36,112	-42,701	-49,304	-52,143	-61,375	-69,587	-79,165	-86,880	-93,357	-96,817	-100,201	-102,867	-106,339	-97,027	-99,810	83,392	77,574	75,278	75,343	73,810	71,507	69,995	68,638	67,118	65,313	77,826	76,197	74,649	73,686	72,099	67,547	63,495	58,042	54,275	50,462	47,028	44,700	0	0	0	0	45,340	44,172	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt	7,214	9,665	4,606	4,546	4,491	4,434	4,390	4,333	4,278	4,223	4,168	4,113	4,061	4,008	3,966	4,631	4,378	4,133	4,890	5,464	3,667	3,623	3,575	53	1,067	1,693	2,209	2,825	2,683	0	0	0	2,402	0	0	0	2,328	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt Total	38,956	23,829	19,964	21,076	22,181	23,271	24,434	25,494	26,547	27,583	28,602	29,607	30,608	31,591	32,593	33,224	34,173	35,110	37,029	38,687	3,667	38,934	39,691	53	1,067	1,780	2,209	2,825	2,683	2,460	4,629	5,212	2,402	6,407	7,025	7,613	2,328	2,310	9,377	2,273	2,256	10,986	11,714	12,215	12,436	13,076	2,093	2,072	14,811	1,878	3,260	15,707	16,160	1,809	819	808	7,719	765	820	11,008	12,954	239	3,256	6,617	2,993	4,815	6,763	11,093	11,093	3,001	12,700	200	1,471	4,784	4,823	4,862	4,901	4,937	4,973	5,008	5,043	5,077	5,109	5,142	5,302	5,207	5,247	5,276	5,302	5,334	5,366	5,398	5,430	5,724	5,727	4,071	3,600	2,100	100	1,600	100	100	100	0	0	-	-	-
Short Term Debt	7,817	9,665	4,606	4,546	4,491	4,434	4,390	4,333	4,278	4,223	4,168	4,113	4,061	4,008	3,966	4,631	4,378	4,133	4,890	5,464	3,667	3,825	3,662	53	1,067	1,780	2,209	2,600	2,683	2,460	2,522	2,488	2,402	2,462	2,477	2,467	2,328	2,310	2,465	2,273	2,256	2,348	2,511	12,215	12,436	13,076	2,093	2,072	1,861	1,878	3,260	1,843	1,827	1,809	819	808	816	765	820	2,821	4,581	239	3,256	6,266	1,093	1,036	686	3,110	3,110	3,001	4,339	200	1,471	166	162	159	156	153	149	146	142	139	136	133	132	128	128	128	132	127	131	135	135	392	5,715	4,058	3,600	2,000	0	1,500	0	0	0	0	0	-	-	-
Short Term Investments	0	0	8,692	8,692	8,692	0	8,692	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	99	497	753	1,110	1,110	1,243	1,677	8,692	9,452	14,641	15,563	15,019	15,348	14,597	13,338	12,515	12,766	12,155	11,089	10,858	6,637	8,932	7,435	7,124	6,637	5,025	6,027	7,718	6,577	5,990	7,624	11,753	10,900	10,700	7,300	0	0	0	0	0	0	-	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Assets	122,437	120,136	133,627	134,306	130,461	134,983	136,233	153,154	157,540	156,186	151,849	146,878	133,423	127,246	116,781	115,855	110,685	107,649	104,275	104,571	107,684	108,717	102,885	130,976	127,316	128,740	124,576	126,059	120,624	119,301	116,499	118,370	129,099	129,476	131,048	128,452	129,510	127,063	121,868	116,277	110,996	109,914	104,899	103,502	100,046	109,429	105,594	103,378	100,676	100,952	100,298	98,003	95,770	93,400	78,824	77,384	72,499	74,406	72,264	73,334	72,145	60,764	61,169	62,194	61,869	64,041	63,292	61,532	61,532	60,265	61,747	44,222	44,675	49,226	48,365	48,708	47,954	46,228	46,595	46,262	45,673	43,375	43,159	41,848	33,772	37,261	35,910	34,166	33,772	33,198	33,088	31,896	31,637	32,323	32,005	30,527	29,300	27,200	25,300	25,900	26,300	24,200	25,400	23,100	22,600	-	-	-
Total Current Assets	24,360	24,743	40,987	45,172	43,716	49,105	51,780	68,921	73,707	72,726	67,589	62,235	54,112	47,366	36,697	34,939	29,157	26,570	22,888	22,873	28,062	28,770	23,633	52,278	52,259	53,822	50,983	52,383	47,065	45,917	42,741	44,814	56,111	56,067	55,771	53,171	53,188	53,202	47,475	42,275	36,474	34,908	29,665	27,869	23,815	32,451	28,224	25,259	22,137	21,627	20,845	20,181	17,341	16,365	19,513	17,226	11,664	13,324	11,019	12,707	10,439	11,954	12,282	13,583	12,600	15,117	14,385	12,997	12,997	11,672	12,814	17,870	18,218	23,087	26,291	26,406	25,454	23,683	23,813	23,504	23,521	21,213	20,808	19,496	12,292	16,168	14,773	12,964	12,292	11,297	11,136	13,898	13,250	14,111	15,609	15,391	15,800	14,700	13,900	15,000	17,300	17,800	20,000	22,200	21,900	-	-	-
Total Current Liabilities	36,203	40,805	33,736	36,112	33,417	41,084	39,587	41,569	40,388	39,170	39,979	36,938	31,681	32,073	32,268	39,879	38,155	38,312	37,076	39,238	46,761	35,437	32,917	29,484	32,310	34,167	30,851	34,351	31,514	31,131	29,270	32,518	44,171	31,584	29,282	27,594	27,926	26,987	25,287	23,938	23,690	26,127	24,742	35,748	35,298	37,687	25,272	24,417	24,399	26,656	27,147	25,727	26,150	25,263	20,739	19,408	16,095	19,240	19,040	21,052	21,089	18,818	20,616	22,179	14,984	15,439	14,801	14,479	14,479	14,427	16,733	8,514	10,160	8,284	9,032	6,834	6,020	6,112	7,433	7,304	6,704	5,813	6,953	6,630	5,032	5,247	5,584	5,042	5,032	4,963	5,804	4,608	4,908	6,271	12,156	11,370	10,600	8,700	7,400	8,100	8,300	5,600	7,400	4,100	4,200	-	-	-
Total Liab	73,482	62,264	55,877	59,641	58,428	67,217	67,609	71,668	72,203	73,058	75,484	73,628	69,108	70,517	71,207	78,558	77,793	78,674	78,308	81,832	88,601	78,578	76,068	35,612	37,275	39,896	36,746	40,487	37,818	38,076	36,841	42,200	54,877	42,886	41,353	40,609	41,762	40,755	39,790	38,958	39,241	42,376	41,664	43,555	43,304	45,360	44,531	44,971	45,122	47,442	47,754	46,867	47,186	45,718	32,456	31,280	28,328	31,835	30,964	33,140	33,546	21,156	22,768	24,826	19,582	22,427	23,842	24,781	24,781	23,942	26,674	10,372	12,082	15,081	15,851	13,696	12,936	12,586	13,809	13,731	13,249	12,152	13,255	12,865	10,419	10,738	11,050	10,494	10,419	10,182	11,051	9,922	10,255	11,682	12,248	11,461	10,700	9,100	7,800	8,500	8,900	6,300	8,100	4,400	4,500	-	-	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Stockholder Equity	48,955	57,872	77,750	74,665	72,033	67,766	68,624	81,486	85,337	83,128	76,365	73,250	64,315	56,729	45,574	37,297	32,892	28,975	25,967	22,739	19,083	30,139	26,817	95,364	90,041	88,844	87,830	85,572	82,806	81,225	79,658	76,170	74,222	86,590	89,695	87,843	87,748	86,308	82,078	77,319	71,755	67,538	63,235	59,947	56,742	64,069	61,063	58,407	55,554	53,510	52,544	51,136	48,584	47,682	46,368	46,104	44,171	42,571	41,300	40,194	38,598	39,607	38,401	37,368	42,286	41,614	39,450	36,751	36,750	36,324	35,072	33,850	32,593	34,144	32,514	35,012	35,018	33,641	32,786	32,531	32,424	31,224	29,904	28,983	23,353	26,523	24,860	23,672	23,353	23,015	22,037	21,974	21,382	20,642	19,757	19,066	18,600	18,100	17,500	17,400	17,400	17,900	17,300	18,700	18,100	-	-	-
Treasury Stock	0	0	0	0	-78,267	-75,949	-72,303	-56,828	-50,149	-44,937	-44,937	-44,937	-43,727	-41,144	-40,228	-38,151	-33,726	-32,320	-30,257	-30,120	-29,004	-27,195	-26,684	-38,225	-36,953	-35,057	-35,036	-34,547	-32,830	-32,830	-32,538	-32,376	-32,229	-32,031	-30,735	-30,378	-30,058	-29,716	-29,716	-29,716	-28,810	-28,810	-28,810	-28,810	-28,604	-26,147	-25,331	-25,214	-23,436	-23,265	-22,989	-22,919	-22,845	-22,845	-22,845	-22,682	-22,382	-22,377	-22,371	-22,365	-22,298	-19,614	-18,806	-18,717	-12,165	-12,105	-12,040	-11,976	-11,924	-11,698	-10,752	-10,688	-10,688	-8,017	-8,017	-5,050	-4,756	-4,703	-3,684	-3,067	-1,869	-1,645	-1,596	-1,596	-1,596	-1,522	-1,503	-1,503	-1,503	-1,503	-1,503	-1,503	-1,503	-1,491	-1,491	-1,491	0	0	0	0	0	0	0	0	0	-	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31
Begin Period Cash Flow	25,026	54,361	34,690	13,517	12,991	34,733	33,021	42,145	40,042	22,092	8,286	8,082	3,519	2,512	1,109	3,355	876	844	3,648	3,441	991	3,219	3,219	1,150	4,900	4,700	2,800	900
Capital Expenditures	15,779	9,835	5,514	3,984	4,656	5,971	4,818	3,973	2,939	2,492	2,188	2,348	2,812	1,539	2,909	2,812	1,956	1,453	1,088	2,067	1,683	1,543	1,543	6,194	4,900	7,800	300	300
Cash And Cash Equivalents Changes	0	-29,153	19,671	21,173	526	-21,742	1,712	-9,124	2,103	17,950	13,806	204	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	3,481	1,295	-2,195	-1,159	-1,398	-565	-535	207	-2	-90	-459	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	-18,373	-29,335	19,671	21,173	526	-21,742	1,712	-9,124	2,103	17,950	13,806	204	4,563	1,007	1,403	-2,246	2,479	32	-2,804	207	2,450	-2,139	-2,139	2,069	-3,800	-1,200	12,500	-3,300
Change In Working Capital	1,025	-3,351	1,841	-4,612	616	1,450	-806	-499	472	3,111	-979	-1,207	-273	-27	-1,009	3,443	3,907	-2,564	730	289	1,443	-866	-866	-2,377	1,100	600	-1,600	2,300
Change Receivables	0	-733	343	-2,271	311	2,767	-2,340	-1,137	-2,167	2,980	584	-890	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	2,084	-733	343	-2,271	311	2,767	-2,463	-1,044	-1,777	2,914	970	-879	-2,064	-2,489	1,396	636	616	0	0	2,161	0	0	0	0	0	0	0	0
Change To Inventory	0	0	-1,127	543	277	-1,399	1,317	-188	572	-303	-264	1,128	2,922	1,616	-1,230	13,864	900	0	29	0	961	0	0	0	0	0	0	0
Change To Liabilities	0	-3,530	203	-406	1,464	81	2,099	1,173	2,432	133	-1,473	146	1,228	0	0	0	257	0	931	0	112	0	0	0	0	0	0	0
Change To Netincome	0	-30	663	743	2,356	2,888	1,368	2,599	-305	1,126	1,078	568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	-21	-378	208	-450	-1,512	1,194	-95	962	-369	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	5,899	5,277	6,374	7,505	5,539	5,463	4,586	4,225	4,109	3,804	3,732	4,699	5,065	4,704	3,831	2,686	2,583	2,260	1,762	2,018	1,941	1,917	1,917	1,270	800	400	200	200
Dividends Paid	36,366	20,961	9,159	10,517	31,299	16,859	16,867	28,552	10,054	10,054	2,142	17,363	5,912	5,061	4,263	3,771	3,324	2,756	2,258	0	0	0	0	0	0	0	4,400	3,300
End Period Cash Flow	6,653	25,026	54,361	34,690	13,517	12,991	34,733	33,021	42,145	40,042	22,092	8,286	8,082	3,519	2,512	1,109	3,355	876	844	3,648	3,441	1,080	1,080	3,219	1,100	3,500	15,300	-2,400
Exchange Rate Changes	0	0	3	-236	611	-1,122	855	285	-1,588	-794	-497	107	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	22,334	26,430	40,830	36,652	36,261	33,877	23,273	22,870	18,947	23,705	17,127	16,784	15,669	13,064	10,757	12,363	12,610	5,359	7,100	5,750	6,582	1,536	1,536	-4,171	-1,400	-3,800	1,200	6,000
Investments	-13,974	-9,835	-8,514	-3,724	-4,656	-5,971	-1,300	-3,750	-1,300	-1,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-4,397	-4,093	-3,604	-3,715	36,585	-2,581	-2,294	-2,501	-2,412	-2,222	-2,158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	30,963	31,800	37,466	37,260	32,406	30,047	22,943	20,518	17,610	18,156	15,484	15,068	11,564	8,499	8,491	7,445	6,839	5,884	5,236	4,551	4,384	1,670	1,670	2,717	1,500	500	3,200	2,300
Other Cashflows From Financing Activities	28,646	-2,232	-721	-1,086	19,897	-2,040	-21,116	-2,000	-2,549	1,030	755	2,078	5,374	-18	17	680	80	19,585	-3,429	-286	-132	-128	-128	1,819	800	-100	100	-1,200
Other Cashflows From Investing Activities	0	0	-3,000	260	260	260	-250	223	1,613	-3,231	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	8	3,068	7	-248	-6	186	207	-195	-327	277	107	605	-1	34	1	156	1,124	1,086	-1	345	1	23	53	33	100	2,500	0	1,500
Sale Purchase Of Stock	-19,099	-27,616	-4,142	1,734	-1,103	-72,370	-1,668	-204	-1,765	-348	-55	-527	0	-399	-84	-9,007	-241	-1,236	-8,191	-2,886	-274	-93	0	-12	-300	-1,100	0	0
Stock Based Compensation	935	1,200	623	680	1,224	1,514	1,845	1,929	1,383	742	955	388	763	779	619	1,016	-4	48	197	0	165	30	0	26	0	0	0	0
Total Cash From Financing Activities	-40,707	-55,583	-18,162	-15,503	-36,346	-54,497	-21,116	-32,502	-16,869	-1,730	-2,824	-16,687	-6,886	3,254	-9,548	-1,755	-11,246	6,897	-11,366	-2,839	-205	133	133	1,932	500	-1,200	12,500	-3,300
Total Cash From Operating Activities	38,113	36,265	46,344	40,636	40,917	39,848	28,091	26,843	21,886	26,197	19,315	19,132	18,481	14,603	13,666	15,175	14,566	6,812	8,188	7,817	8,265	3,080	3,080	2,023	3,500	4,000	1,500	6,300
Total Cashflows From Investing Activities	0	-9,835	-8,514	-3,724	-4,656	-5,971	-6,118	-3,750	-1,326	-5,723	-2,188	-2,348	0	0	0	0	0	0	354	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31
Begin Period Cash Flow	3,828	22,496	23,724	25,026	28,392	32,974	47,290	54,361	52,482	48,899	43,454	34,690	21,855	11,957	10,021	13,517	8,358	4,020	2,641	12,991	7,273	6,698	35,478	34,733	35,750	31,628	34,664	33,021	28,878	27,192	25,366	42,145	37,580	40,555	37,010	40,042	39,063	31,539	26,453	22,092	18,934	10,802	9,234	8,286	15,026	11,168	7,872	8,082	6,223	4,464	3,316	3,519	3,195	7,236	6,261	2,512	1,460	404	620	1,109	677	1,309	1,486	3,355	2,059	2,122	1,358	1,387	1,387	575	1,031	844	1,036	3,125	5,326	3,648	2,543	3,942	5,227	3,441	3,947	2,698	1,257	991	2,924	1,870	1,233	1,080	2,924	1,137	2,673	3,219	4,912	3,724	330	1,150	1,100	2,500	4,000	4,900	0	0	3,900	4,700	4,400
Capital Expenditures	3,770	4,470	4,340	3,199	1,966	3,983	1,344	2,542	1,717	992	1,567	1,238	1,549	1,008	837	590	1,227	1,149	1,146	1,134	1,113	2,085	1,475	1,298	1,221	1,207	965	1,425	907	849	1,133	1,084	732	575	875	757	392	675	820	605	627	595	550	416	458	606	651	633	536	969	547	760	442	509	249	339	385	441	1,307	776	544	921	620	728	893	342	345	406	406	255	419	374	362	258	246	221	178	285	527	1,077	387	360	431	505	273	342	694	266	273	433	292	545	1,148	1,636	2,194	1,216	1,800	3,800	800	2,100	900	600	6,000	300	50
Cash And Cash Equivalents Changes	0	0	-1,228	-1,302	-3,408	-4,406	-14,229	-7,110	1,879	3,583	5,445	8,764	12,835	9,898	1,936	-3,496	5,159	4,338	1,379	-10,350	5,718	575	-28,780	745	-1,017	4,122	-3,036	1,643	4,143	1,686	1,826	-16,779	4,565	-2,975	3,545	-3,032	979	7,524	5,086	4,361	3,158	8,132	1,568	948	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-551	-3,245	2,438	2,897	-613	-1,241	-753	1,529	-721	1,240	-1,192	15	-189	-829	-4,491	2,781	-277	828	233	760	-1,983	-408	709	422	-1,156	-540	-220	322	-383	-254	486	317	-222	-374	174	186	119	-481	356	73	113	-632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	2,825	-18,668	-1,228	-1,302	-3,366	-4,582	-14,316	-7,071	1,879	3,583	5,445	8,764	12,835	9,898	1,936	-3,496	5,159	4,338	1,379	-10,350	5,718	575	-28,780	745	-1,017	4,122	-3,036	1,643	4,143	1,686	1,826	-16,779	4,565	-2,975	3,545	-3,032	979	7,524	5,086	4,361	3,158	8,132	1,568	948	-6,740	3,858	3,296	-210	1,859	1,759	1,148	-203	324	-4,041	975	3,749	1,052	1,056	-216	-489	432	-631	-177	-1,869	1,296	-63	764	-511	-511	812	-456	187	-192	-2,089	-2,200	1,678	1,104	-1,399	-1,285	1,786	-506	1,248	1,441	266	-1,844	-212	637	153	-1,844	1,787	-1,536	-546	-1,694	1,189	3,393	-819	0	-1,400	-1,500	-1,300	-1,200	-500	-2,500	-800	300
Change In Working Capital	1,408	268	5	-656	-2,969	519	551	-1,452	786	-2,271	287	3,039	5,143	-467	-925	-8,363	1,249	2,575	-600	-2,608	4,701	-1,695	-360	-1,196	-915	5,256	-4,766	-381	1,832	492	476	-3,299	1,576	-2	2,620	-3,722	-222	3,540	1,074	-1,281	-888	4,292	-1,776	-2,607	311	931	1,102	-3,551	-683	1,699	452	-1,741	-1,464	-325	142	1,620	-362	-1,107	1,507	-1,046	233	1,578	2,547	-915	2,032	-627	560	-1,560	1,274	510	-904	-610	-281	-707	637	1,081	109	-1,322	-662	2,164	-1,245	771	741	1,176	-1,020	-457	8	124	926	-294	307	140	-1,049	-60	-1,253	-15	-1,300	300	1,100	1,000	-3,200	-900	200	1,300	13,900
Change Receivables	0	0	2,328	242	922	-2,269	2,778	-2,164	2,531	-2,148	169	-209	3,559	2,552	-2,496	-5,886	3,654	-255	846	-3,934	4,608	-5,796	3,560	395	-42	1	722	-3,021	2,919	-2,475	2,553	-4,134	2,899	-2,460	1,409	-4,015	2,795	1,023	240	-1,078	1,104	2,884	-474	-2,930	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	2,090	-2,576	2,328	242	922	-2,269	2,778	-2,164	2,531	-2,148	169	-209	3,559	2,552	-2,496	-5,886	3,654	-255	846	-3,934	4,609	-5,797	3,560	395	111	-357	430	-2,647	3,153	-2,972	2,942	-4,167	3,324	-2,834	1,571	-3,838	2,873	441	675	-1,075	260	3,258	-251	-2,297	2,005	-1,009	465	-2,340	1,144	-808	1,308	-3,708	595	-398	186	-2,872	3,254	-1,003	2,298	-3,153	636	0	0	-3,171,809	616	0	0	-2,155,711	0	0	0	-236,344	0	0	0	-255,950	2,161	1,397	1,649	2,058,063	0	2,174	628	0	0	0	0	0	0	117	0	0	0	1,262	618	1,044	0	0	0	0	0	0	0	0	-1,100
Change To Inventory	-1,450	1,554	-104	0	0	0	0	0	-1,156	-1,489	1,682	-164	1,461	-1,074	3,231	-3,075	-839	1,220	2,740	-2,844	1,543	1,822	-1,887	-2,877	2,608	1,237	-8	-2,520	76	1,356	-1,457	-163	-194	2,192	-942	-484	-395	2,054	-846	-1,116	1,653	755	-169	-2,503	361	2,104	6	-1,343	1,497	1,171	211	43	-403	1,042	61	916	-2,838	365	330	913	603	679	199	2,953,380	900	904	283	2,286,125	0	0	0	517,852	29	0	0	12,500	0	0	59	-2,478,168	961	250	788	473	0	0	0	0	0	0	346	21	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Liabilities	0	0	-1,772	2,347	-3,760	-109	-1,614	1,953	-992	-1,652	-1,244	2,008	2,776	-3,294	1,760	-1,648	2,086	49	-1,169	498	-141	3,342	-1,937	-1,183	-1,582	4,833	-4,332	3,180	-867	2,645	-1,694	1,089	-1,809	2,141	1,433	667	-3,191	2,331	715	278	-2,348	1,335	-1,416	956	1,086	1,130	0	0	1,228	1,667	1,237	313	0	0	773	908	0	321	420	710	0	369	0	0	257	39	90	195	0	0	0	0	931	458	764	0	0	86	162	475	112	176	109	41	0	0	0	212	0	0	0	16	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	0	37	51	488	-63	-342	-113	297	-80	99	153	-20	-181	184	760	742	744	573	297	-56	859	1,250	835	-201	318	354	897	188	488	731	1,192	-1,393	336	-53	805	710	201	159	56	154	358	279	287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	133	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	0	-4,040	-1,030	1,866	639	-1,496	-742	-1,128	1,895	-403	1,470	-1,038	3,548	-3,772	-1,048	965	2,632	-2,999	1,429	1,821	-1,685	-3,077	1,194	879	-300	-2,146	-95	0	0	0	962	0	0	0	-369	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1,429	1,554	1,521	1,394	1,375	1,296	1,290	1,316	1,358	1,398	1,634	1,984	2,882	1,846	1,406	1,371	1,254	1,430	1,440	1,415	1,467	1,388	1,325	1,283	1,210	1,132	1,138	1,106	1,079	1,086	1,092	968	1,000	1,070	1,024	1,015	994	949	926	935	944	906	932	950	1,093	1,149	1,214	1,243	1,275	1,312	1,235	1,243	1,322	1,225	1,059	1,098	929	901	891	1,110	683	661	676	666	661	672	623	689	689	600	500	470	428	456	454	424	526	538	489	464	477	536	482	446	540	401	418	405	540	509	465	403	288	352	356	273	200	200	200	200	200	100	0	100	40
Dividends Paid	2,947	27,512	2,951	2,956	5,926	5,944	6,047	3,044	3,054	3,052	3,053	10,517	10,517	10,517	5,278	5,239	4,735	4,727	4,725	17,112	4,209	4,205	4,224	4,221	4,218	4,218	4,218	4,213	3,372	3,371	3,369	18,440	2,509	2,516	2,518	2,511	10,054	0	0	0	2,142	2,142	2,142	2,142	12,064	1,774	1,763	1,762	1,477	1,479	1,479	1,477	1,267	1,265	1,264	1,265	1,066	1,066	1,066	1,066	929	937	936	969	831	831	831	689	689	688	691	688	2,258	560	575	575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	6,653	3,828	22,496	23,724	25,026	28,392	32,974	47,290	54,361	52,482	48,899	43,454	34,690	21,855	11,957	10,021	13,517	8,358	4,020	2,641	12,991	7,273	6,698	35,478	34,733	35,750	31,628	34,664	33,021	28,878	27,192	25,366	42,145	37,580	40,555	37,010	40,042	39,063	31,539	26,453	22,092	18,934	10,802	9,234	8,286	15,026	11,168	7,872	8,082	6,223	4,464	3,316	3,519	3,195	7,236	6,261	2,512	1,460	404	620	1,109	677	1,309	1,486	3,355	2,059	2,122	876	876	1,387	575	1,031	844	1,036	3,125	5,326	3,648	2,543	3,942	5,227	3,441	3,947	2,698	1,257	1,080	1,658	1,870	1,233	1,080	2,924	1,137	2,673	3,219	4,912	3,724	330	1,100	1,100	2,500	3,600	-1,200	-500	-2,500	3,900	4,700
Exchange Rate Changes	0	0	0	0	0	0	0	0	4	-69	45	23	88	150	419	-893	214	-124	217	304	-777	250	-261	-334	27	429	313	86	-199	-202	89	597	-393	-653	176	-718	-421	-420	284	-237	-256	115	-219	-137	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	7,938	5,347	4,495	4,554	6,138	6,067	8,477	5,748	10,357	7,712	9,591	13,170	14,668	9,508	7,543	4,933	10,716	11,719	7,660	6,166	12,799	5,460	8,688	6,930	5,390	9,653	1,512	6,718	7,917	5,945	6,058	2,950	6,378	4,968	6,780	821	5,189	8,567	5,391	4,558	3,350	8,774	2,318	2,685	5,080	5,187	5,069	1,448	3,582	5,136	3,835	3,116	1,807	2,691	2,654	5,912	3,008	2,189	2,940	2,621	2,827	3,799	4,335	1,402	3,299	2,540	2,773	704	704	3,248	549	858	1,411	1,647	1,832	2,210	2,055	780	264	2,651	387	2,352	1,753	2,090	-306	1,105	665	651	-306	754	562	526	-803	-495	-2,466	-407	1,400	-2,500	500	-800	500	-600	-5,300	1,600	-1,140
Investments	-3,770	-4,470	-4,339	-3,199	-1,966	-3,983	-1,344	-2,542	-1,717	-992	-1,567	-4,238	-1,549	-748	-837	-590	-1,227	-1,149	-1,146	-1,134	0	0	0	0	-1,300	-1,300	-1,300	-1,300	-1,300	0	0	0	-1,300	0	0	0	-1,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	-1,122	-1,114	-1,189	-1,081	-1,067	-1,060	-1,044	-1,026	-1,138	-1,009	-993	-1,011	-641	-959	-948	-1,930	-1,669	832	-954	-930	39,564	-1,095	-653	-442	-643	-843	-426	-630	-619	-619	-613	-634	-628	-626	-609	-624	-592	-587	-581	-757	-531	-353	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	8,855	7,877	7,272	6,964	6,641	8,298	8,322	8,539	9,633	9,657	8,944	9,232	8,212	9,578	7,715	11,755	8,698	8,119	7,393	8,196	7,801	6,992	7,948	7,306	6,517	4,154	5,751	6,521	5,725	4,728	4,892	5,173	5,927	4,139	4,064	3,480	4,099	4,552	4,052	5,453	3,767	3,813	3,434	4,470	3,703	3,577	3,939	3,849	3,132	2,647	2,329	3,456	1,568	2,142	1,661	3,128	2,238	1,994	1,609	2,650	1,895	1,966	1,581	2,003	1,109	2,495	1,641	1,006	1,006	2,342	1,319	1,217	1,534	2,029	925	748	921	1,716	739	1,175	1,255	1,300	908	921	192	1,427	895	294	192	932	43	503	741	831	650	494	600	700	100	100	700	600	-1,400	600	1,100
Other Cashflows From Financing Activities	26,263	4,992	283	301	-92	-190	-16,659	-1,950	-4,260	141	-3,053	-298	9,734	1,018	-41	-1,280	-82	3,962	8,000	8,017	-1,141	1,500	-31,734	-535	-1,563	-2,507	-965	-105	57	-56	-333	-1,667	133	-2,782	6	94	91	-675	3	936	180	-595	-550	575	725	755	300	599	54	328	2,818	2,174	-38	11,410	36	-565	11	2	3	2	12,321	179	77	7,372	9	23	38	-17	-17	75	12,553	-1,105	-1,601	-39	-39	-39	-179	-35	-36	-35	-33	-81	-33	-34	-32	-59	-29	-26	-1,916	-31	-32	-33	-330	-4	1,689	452	-1,200	4,600	-1,400	-1,200	-1,200	-500	-3,200	-2,700	-2,220
Other Cashflows From Investing Activities	0	0	1	0	0	0	0	0	0	0	0	-3,000	0	260	260	260	260	0	0	0	0	0	0	0	0	-250	0	0	223	0	0	0	1,613	0	0	0	-3,231	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	4	-1,555	215	124	2,731	132	105	100	-204	54	90	67	-138	-253	63	80	216	-11	-231	20	271	-179	42	52	95	39	29	44	-153	4	35	-81	-1,034	-3	26	684	178	25	2	72	50	0	0	57	603	-1	3	3,849	3,132	-1	0	0	17	12	5	0	0	1	0	0	330	309	301	-226,167	268	293	273	286	286	275	309	-215,124	-122	51	63	-33,802	115	50	148	-31,780	148	18	0	0	54	0	-1	0	0	0	0	0	35	0	0	23	100	100	-100	0	3,700	200	1,900	-100	-15,850
Sale Purchase Of Stock	-14,999	-309	-1,819	-1,972	-2,317	-3,145	-15,475	-6,679	-4,000	142	0	162	142	1,054	538	0	0	0	0	0	0	0	0	0	0	0	0	-57	-57	-56	0	-147	-44	-1,358	-271	-92	-40	1	0	-309	55	0	0	-55	-302	0	385	372	0	0	0	64	64	0	-163	-300	-5	-6	-6	-67	-1,559	-808	-89	-6,551	-61	-65	-64	-226	-226	-946	0	-4,930	-4,930	0	-2,967	-294	-53	-1,019	-616	-1,198	-225	0	0	0	-74	0	0	0	0	0	0	0	0	0	0	0	-100	0	-100	-100	0	0	0	0	16,840
Stock Based Compensation	258	68	305	304	290	291	334	285	348	126	203	-54	-67	274	141	332	307	308	307	302	259	260	540	455	572	481	342	450	381	467	545	536	458	372	369	184	344	268	242	-112	249	249	239	218	209	97	30	52	225	40	278	220	213	198	182	186	207	28	216	168	0	0	0	226,399	-4	0	0	48	0	0	0	215,339	133	0	0	33,873	0	0	0	31,812	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-5,112	-24,015	-5,724	-5,856	-9,546	-10,473	-22,706	-12,858	-8,482	-4,060	-4,191	-1,429	-1,921	-20	-6,026	-7,536	-5,771	-7,257	-6,498	-16,820	-6,304	-5,135	-37,207	-5,851	-6,434	-4,660	-4,861	-5,161	-3,798	-4,057	-4,321	-20,326	-3,033	-7,290	-3,411	-3,135	-558	-623	-589	40	64	-757	-531	-1,600	-11,773	-1,520	-1,639	-1,755	-1,757	-3,041	-237	-1,851	-1,553	8,470	-1,597	-2,066	-1,882	-1,320	-3,269	-3,077	9,833	-3,966	-4,258	-3,363	-2,551	-2,806	-2,320	-779	-779	-2,901	12,037	-1,460	-6,427	-582	-3,544	-814	-100	-1,018	-548	-1,173	-185	-11	-23	14	105	183	228	18	105	4	-6	31	-305	50	1,729	458	-1,300	4,600	-1,500	-1,300	-1,200	0	0	0	14,620
Total Cash From Operating Activities	11,708	9,817	8,835	7,753	8,104	10,050	9,821	8,290	12,074	8,704	11,158	14,408	16,217	10,516	8,380	5,523	11,943	12,868	8,806	7,300	13,912	7,545	10,163	8,228	6,611	10,860	2,477	8,143	8,824	6,794	7,191	4,034	7,110	5,543	7,655	1,578	5,581	9,242	6,211	5,163	3,977	9,369	2,868	3,101	5,538	5,793	5,720	2,081	4,118	6,105	4,382	3,876	2,249	3,200	2,903	6,251	3,393	2,629	4,247	3,397	3,371	4,720	4,955	2,130	4,192	2,882	3,118	1,110	1,110	3,502	968	1,231	1,773	1,905	2,078	2,431	2,233	1,065	792	3,728	774	2,712	2,184	2,595	-32	1,447	1,360	916	-32	1,187	854	1,071	345	1,142	-272	809	-400	1,300	1,300	1,300	1,400	0	700	1,900	-1,090
Total Cashflows From Investing Activities	0	0	-4,339	-3,199	-1,966	-3,983	-1,344	-2,542	-1,717	-992	-1,567	-4,238	-1,549	-748	-837	-590	-1,227	-1,149	-1,146	-1,134	-1,113	-2,085	-1,475	-1,298	-1,221	-2,507	-965	-1,425	-684	-849	-1,133	-1,084	881	-575	-875	-757	-3,623	-675	-820	-605	-627	-595	-550	-416	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	415	354	0	0	55	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31
Cost Of Revenue	61,914	57,049	52,350	49,187	46,435	47,577	49,068	45,577	44,610	41,719	38,844	35,461	28,667	24,635	24,574	23,611	21,801	19,446	13,642	12,869	12,029	8,059	8,059	9,120	11,100	9,400	7,200	5,700	3,495	2,967	1,083
Depreciation And Amortization	5,899	5,327	6,392	7,575	5,114	5,463	4,586	4,225	4,109	3,804	3,732	4,699	5,065	4,704	3,831	2,685	2,583	2,260	1,762	2,018	1,941	1,917	1,917	1,270	800	400	200	200	119	86	50
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Ebit	40,086	46,543	50,270	42,677	43,035	36,222	34,365	31,546	27,580	28,397	24,885	22,748	18,748	13,863	13,699	12,031	11,269	9,964	8,424	7,406	6,879	2,733	2,624	3,363	2,500	5,300	6,200	3,600	2,939	1,658	511
Ebitda	45,985	51,870	56,662	50,252	48,149	41,685	38,951	35,771	31,689	32,201	28,617	27,447	23,813	18,567	17,530	14,716	13,852	12,223	10,186	9,424	8,820	4,650	4,541	4,633	3,300	5,700	6,400	3,800	3,058	1,744	561
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Extraordinary Items	0	0	0	0	0	0	1,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Gross Profit	86,666	94,519	95,604	84,090	81,547	72,109	68,491	63,807	57,733	57,118	53,746	50,960	47,100	38,763	33,118	27,402	27,122	24,326	18,794	16,814	14,893	9,615	9,615	9,196	7,100	8,300	9,100	6,900	5,422	3,788	1,728
Income Before Tax	39,962	42,815	48,621	41,467	40,519	34,709	34,283	31,356	27,360	28,092	24,488	22,207	18,160	13,315	13,117	11,983	11,117	9,506	8,514	7,283	6,916	2,624	2,624	3,856	2,200	800	3,600	3,800	3,047	1,704	523
Income Tax Expense	8,991	11,015	11,155	4,207	8,113	4,662	11,340	10,838	9,750	9,936	9,004	7,139	6,596	4,816	4,626	4,538	4,278	3,622	3,278	2,732	2,532	954	954	1,139	700	300	400	1,500	-	114	9
Interest Expense	1,428	1,209	1,667	1,813	2,091	1,513	82	190	220	305	397	541	629	491	405	139	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	913	168	14	18	37	62	96	47	160	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Income	30,971	31,800	37,466	37,260	32,406	30,047	22,943	20,518	17,610	18,156	15,484	15,068	11,564	8,499	8,491	7,445	6,839	5,884	5,236	4,551	4,384	1,670	1,670	2,717	1,500	500	3,200	2,300	3,047	1,590	514
Net Income Applicable To Common Shares	0	31,800	37,466	37,260	32,406	30,047	45,886	41,037	35,220	36,312	15,484	15,068	11,564	8,499	8,491	7,445	6,839	5,884	5,236	4,551	4,384	3,850	1,670	2,717	0	0	0	0	-	-	-
Net Income From Continuing Ops	28,754	31,800	37,466	37,260	32,406	30,047	22,943	20,518	17,610	18,156	15,484	15,068	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Interest Income	33	-1,041	-1,653	-1,795	-2,054	-1,451	14	-143	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Operating Income Net Other	0	-2,519	18	603	-425	947	146	349	1,133	101	79	29	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Operating Income	40,086	46,543	50,270	42,677	43,035	35,275	34,219	31,197	26,447	28,296	24,806	22,719	18,735	13,857	13,697	11,989	11,366	9,908	8,415	7,402	6,965	2,713	2,713	3,325	2,100	3,100	4,900	3,600	2,939	1,658	511
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Operating Expenses	108,494	105,025	97,684	91,133	84,947	84,411	83,340	78,187	75,896	70,541	67,784	63,702	57,032	49,541	43,995	39,024	37,557	33,864	24,021	22,281	19,957	14,961	14,961	14,992	16,100	14,600	11,400	9,000	5,978	5,097	2,300
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Reconciled Depreciation	5,844	5,277	6,374	7,505	5,539	5,463	4,586	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Research Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling General Administrative	46,092	42,699	38,960	34,441	32,973	31,371	29,686	28,385	27,177	25,018	25,208	23,542	23,300	20,202	15,590	12,728	13,173	12,158	8,617	7,395	5,987	4,985	4,985	4,602	4,200	4,800	4,000	0	-	-	-
Tax Provision	9,212	11,015	11,155	4,207	8,113	4,662	11,340	10,838	9,750	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Operating Expenses	46,580	47,976	45,334	41,946	38,512	36,834	34,272	32,610	31,286	28,822	28,940	28,241	28,365	24,906	19,421	15,413	15,756	14,418	10,379	9,412	7,928	6,902	6,902	5,872	5,000	5,200	4,200	3,300	2,483	2,130	1,217
Total Other Income Expense Net	-124	-3,728	-1,649	-1,210	-2,516	885	50	302	1,073	18	16	-3	41	-57	-177	91	96	-56	-9	-5	86	-20	-89	-38	-400	-2,200	-1,300	200	108	46	12
Total Revenue	148,580	151,568	147,954	133,277	127,982	119,686	117,559	109,384	102,343	98,837	92,590	86,421	75,767	63,398	57,692	51,013	48,923	43,771	32,436	29,683	26,922	17,674	17,674	18,316	18,200	17,700	16,300	12,600	8,917	6,755	2,811

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31
Cost Of Revenue	15,222	14,633	13,309	14,280	13,987	14,524	13,758	14,779	14,167	13,707	12,536	11,940	12,818	12,189	11,634	12,546	11,166	12,109	11,506	11,654	11,892	11,780	10,996	12,909	12,362	12,267	11,939	12,500	11,836	11,468	10,734	11,539	11,365	11,006	10,440	11,799	10,848	9,769	10,773	10,329	9,648	9,452	9,498	10,246	9,128	8,769	8,633	8,931	7,178	7,471	7,260	6,758	6,265	6,038	5,877	6,456	5,547	5,446	6,304	7,276	5,766	6,598	5,320	5,927	5,057	5,930	5,366	4,605	4,605	5,761	4,980	4,100	3,801	4,018	3,073	2,750	2,680	4,175	2,717	3,298	2,748	3,797	2,668	2,816	1,736	3,388	1,780	1,795	1,736	2,689	1,697	1,989	1,407	2,698	2,457	2,557	2,000	3,500	3,000	2,600	2,500	3,400	2,000	1,500	0	-	-	-
Depreciation And Amortization	1,429	1,554	1,521	1,630	1,460	1,322	1,176	1,369	1,357	1,398	1,634	1,984	2,882	1,847	1,406	1,371	1,254	1,430	1,440	1,415	1,467	1,388	1,325	1,283	1,209	1,132	1,138	1,106	1,079	1,086	1,092	968	1,000	1,070	1,024	1,015	994	949	926	935	944	906	932	950	1,093	1,149	1,214	1,243	1,275	1,312	1,235	1,243	1,322	1,225	1,059	1,098	929	901	891	1,110	683	661	676	666	661	672	623	689	689	600	500	470	428	456	454	424	526	538	489	464	477	536	482	446	540	401	418	405	540	509	465	403	288	352	356	273	200	200	200	200	200	100	3,000	100	40	-	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Ebit	11,709	10,200	9,636	9,016	12,241	11,109	11,496	11,697	12,890	13,038	12,317	12,044	10,321	11,584	9,007	11,835	11,843	10,319	10,018	10,430	10,062	8,927	8,258	8,975	8,672	7,191	8,495	10,007	9,036	7,347	7,072	8,091	8,816	6,537	6,382	5,845	6,445	7,183	6,344	8,424	6,033	6,040	5,564	7,250	5,799	5,655	5,222	6,087	5,015	4,198	3,834	5,702	2,360	3,494	2,660	5,348	3,325	3,298	2,702	4,375	3,024	3,127	2,570	3,309	1,812	4,089	2,655	1,913	1,874	3,985	2,151	1,915	2,316	3,309	1,557	1,243	1,376	2,754	1,371	1,905	1,872	2,092	1,407	1,508	376	2,328	1,519	642	367	1,525	82	749	1,005	1,024	746	590	1,200	800	100	200	500	700	700	300	-6,840	-	-	-
Ebitda	13,138	11,754	11,157	10,646	13,701	12,431	12,672	13,066	14,247	14,436	13,951	14,028	13,203	13,431	10,413	13,206	13,097	11,749	11,458	11,845	11,529	10,315	9,583	10,258	9,881	8,323	9,633	11,113	10,115	8,433	8,164	9,059	9,816	7,607	7,406	6,860	7,439	8,132	7,270	9,359	6,977	6,946	6,496	8,200	6,892	6,804	6,436	7,330	6,290	5,510	5,069	6,945	3,682	4,719	3,719	6,446	4,254	4,199	3,593	5,485	3,707	3,788	3,246	3,975	2,473	4,761	3,278	2,603	2,564	4,584	2,652	2,385	2,744	3,765	2,010	1,667	1,902	3,292	1,861	2,369	2,350	2,628	1,889	1,954	916	2,729	1,937	1,047	907	2,035	547	1,152	1,293	1,376	1,102	863	1,400	1,000	300	400	700	800	3,700	400	-6,800	4,700	3,500	3,400
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Gross Profit	22,779	23,312	22,852	22,193	24,157	23,167	23,534	23,662	24,131	24,060	23,889	23,524	21,956	21,288	19,532	21,314	21,457	20,356	19,908	19,826	18,747	18,233	17,021	18,108	17,535	16,684	16,496	17,776	16,532	15,564	15,380	16,331	15,000	14,238	14,024	14,471	14,276	13,913	13,228	15,701	13,275	12,955	12,856	14,660	12,868	12,617	11,999	13,476	11,934	11,078	11,056	13,033	9,618	9,968	8,262	10,914	8,295	8,071	7,290	9,464	6,424	6,870	6,581	7,527	5,764	8,022	6,579	5,713	5,713	7,552	5,683	5,376	4,756	6,114	4,077	3,847	3,750	5,146	3,655	4,263	3,994	4,196	3,461	3,242	2,375	3,929	3,020	2,254	2,375	3,416	1,671	2,101	2,798	2,319	2,182	1,897	2,600	2,100	1,300	1,100	2,100	2,200	2,000	1,900	4,600	4,700	3,500	3,400
Income Before Tax	11,468	10,039	9,444	9,011	9,471	10,847	11,064	11,433	12,491	12,624	11,894	11,612	9,874	11,666	8,557	11,370	11,365	9,809	9,485	9,860	9,540	8,383	7,819	8,967	8,659	7,173	8,471	9,980	9,005	7,309	7,036	8,006	8,768	6,485	6,325	5,782	6,376	7,107	6,266	8,343	5,945	5,948	5,463	7,133	5,674	5,492	5,111	5,930	4,852	4,117	3,687	5,504	2,158	3,333	2,616	5,207	3,189	3,132	2,519	4,277	3,043	3,171	2,499	3,270	1,795	4,053	2,676	1,650	1,650	3,792	2,105	1,958	2,360	3,373	1,540	1,241	1,431	2,795	1,202	1,854	1,921	2,070	1,446	1,479	314	2,281	1,444	468	314	1,482	66	762	1,029	1,187	917	724	800	900	200	200	1,100	1,000	-2,300	1,000	0	-	-	-
Income Tax Expense	2,610	2,163	2,171	2,047	2,830	2,549	2,742	2,894	2,858	2,967	2,950	2,380	1,662	2,088	842	-385	2,667	1,690	2,092	1,664	1,739	1,391	-129	1,661	2,142	3,020	2,719	3,459	3,280	2,580	2,478	2,833	2,841	2,346	2,261	2,302	2,276	2,555	2,215	2,890	2,178	2,135	2,029	2,663	1,971	1,915	1,172	2,081	1,720	1,470	1,358	2,048	590	1,191	956	2,079	951	1,138	910	1,627	1,148	1,205	918	1,267	687	1,558	1,035	644	644	1,450	787	741	826	1,344	615	493	510	1,079	464	679	666	770	538	558	122	854	549	173	122	550	22	259	287	356	266	230	200	300	100	100	400	400	-900	400	-7,940	-900	-600	-700
Interest Expense	269	160	192	241	286	288	318	317	399	413	423	432	447	451	450	465	478	510	533	570	522	544	439	8	13	18	23	27	31	38	36	85	48	52	57	63	69	76	78	81	88	91	101	117	125	134	140	142	149	155	156	169	163	137	93	98	91	91	85	138	21	21,009	53,152	44,052	70	109,839	135,921	167,319	200	225,146	81,964	9,721	76	101,417	101,115	100,811	104	104,601	137	113	106	108	107	107	109	109	126	106	112	113	112	117	89	1	1	1	0	0	0	0	0	0	0	0	0	-	-	-
Interest Income	41	256	273	250	134	15	14	5	4	4	3	3	3	2	2	11	13	10	8	564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Income	8,858	7,876	7,273	6,964	6,641	8,294	8,322	8,539	9,633	9,657	8,944	9,232	8,212	9,578	7,715	11,755	8,698	8,119	7,393	8,196	7,801	6,992	7,948	7,306	6,517	4,153	5,752	6,521	5,725	4,729	4,558	5,173	5,927	4,139	4,064	3,480	4,100	4,552	4,051	5,453	3,767	3,813	3,434	4,470	3,703	3,577	3,939	3,849	3,132	2,647	2,329	3,456	1,568	2,142	1,660	3,128	2,238	1,994	1,609	2,650	1,895	1,966	1,581	2,003	1,109	2,495	1,641	1,006	1,006	2,342	1,319	1,217	1,534	2,029	925	748	921	1,716	738	1,175	1,255	1,300	908	921	192	1,427	895	294	192	932	43	503	741	831	650	494	600	600	100	100	700	600	-1,400	600	1,100	900	600	700
Net Income Applicable To Common Shares	0	0	7,273	6,964	6,641	8,298	8,322	8,539	9,633	9,657	8,944	9,232	8,212	9,578	7,715	11,755	8,698	8,119	7,393	8,196	-14,445	13,984	15,896	14,612	13,034	8,306	11,504	13,042	12,117	9,458	9,116	10,346	11,855	8,277	8,128	6,960	22,256	4,552	4,051	5,453	3,767	3,813	3,434	4,470	3,703	3,576	3,940	3,849	3,132	2,647	2,329	3,456	1,568	2,142	1,661	3,128	2,238	1,994	1,609	2,650	1,895	1,966	1,581	2,003	1,109	2,495	1,641	1,594	1,006	2,342	1,319	1,217	1,534	2,029	925	748	921	1,716	739	1,175	1,255	1,300	908	921	1,234	1,427	895	294	192	932	43	503	742	831	650	494	0	0	0	0	0	0	0	0	0	-	-	-
Net Income From Continuing Ops	8,858	7,876	7,273	6,964	6,641	8,298	8,322	8,539	9,633	9,657	8,944	9,232	8,212	9,578	7,715	11,755	8,698	8,119	7,393	8,196	7,801	6,992	7,948	7,306	6,517	4,153	5,752	6,521	6,058	4,729	4,558	5,173	5,927	4,139	4,064	3,480	4,100	4,552	4,051	5,453	3,767	3,813	3,434	4,470	0	0	0	0	0	2,647	2,329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Interest Income	-227	96	81	9	-152	-273	-304	-312	-395	-409	-420	-429	-444	-449	-448	-454	-465	-500	-525	-564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Operating Income Net Other	0	0	271	236	-2,484	26	-114	53	17	-101	78	24	134	96	-268	641	-119	99	-131	-274	667	-239	502	17	12	69	42	23	202	8	54	85	1,110	-11	18	16	27	24	26	24	6	10	30	33	0	0	0	0	0	78	12	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Operating Income	11,709	9,955	9,365	9,016	12,241	11,109	11,496	11,697	12,873	13,138	12,239	12,020	10,187	12,021	9,275	11,194	11,962	10,220	10,149	10,704	9,395	9,166	7,756	8,958	8,661	7,122	8,452	9,984	8,834	7,339	7,018	8,006	7,706	6,548	6,364	5,829	6,419	7,159	6,318	8,400	6,027	6,029	5,534	7,217	5,774	5,647	5,216	6,082	5,010	4,194	3,831	5,700	2,359	3,493	2,658	5,347	3,324	3,298	2,702	4,374	2,973	3,157	2,557	3,302	1,820	4,110	2,706	1,874	1,874	3,992	2,141	1,900	2,316	3,327	1,534	1,238	1,407	2,783	1,316	1,895	1,911	2,096	1,446	1,512	367	2,328	1,514	576	367	1,523	78	745	1,000	1,014	738	573	1,200	800	100	200	800	900	700	600	-6,800	4,700	3,500	3,400
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Operating Expenses	26,292	27,990	26,796	27,457	25,903	26,582	25,796	26,744	25,425	24,629	24,186	23,444	24,587	21,989	21,891	22,666	20,661	22,245	21,265	20,776	21,244	20,847	20,261	22,059	21,236	21,829	19,983	20,292	19,534	19,693	19,096	19,864	18,659	18,696	18,100	20,441	18,705	16,523	17,683	17,630	16,896	16,378	16,820	17,689	16,222	15,739	15,416	16,325	14,102	14,355	14,485	14,091	13,524	12,513	11,481	12,023	10,518	10,219	10,892	12,366	9,217	10,312	9,344	10,152	9,001	9,842	9,240	8,444	8,444	9,321	8,522	7,576	6,241	6,805	5,616	5,359	5,023	6,537	5,056	5,666	4,832	5,897	4,683	4,546	3,744	4,989	3,286	3,473	3,744	4,582	3,290	3,346	3,206	4,003	3,900	3,882	3,400	4,800	4,200	3,700	3,800	4,700	3,300	2,800	11,400	-	-	-
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Reconciled Depreciation	1,430	1,554	1,521	1,394	1,375	1,296	1,290	1,316	1,357	1,398	1,634	1,984	2,882	1,846	1,406	1,371	1,254	1,430	1,440	1,415	1,467	1,388	1,325	1,283	1,210	1,132	1,138	1,106	1,079	1,086	1,092	968	1,000	1,070	1,024	1,015	994	949	926	935	944	906	932	950	1,093	1,149	1,214	1,243	1,275	1,312	1,235	1,243	1,322	1,225	1,059	1,098	929	901	891	1,110	683	661	676	666	661	672	623	689	689	600	500	470	428	456	454	424	526	538	489	464	477	536	482	446	452	401	418	540	540	509	465	403	288	352	356	273	200	200	200	200	200	100	0	100	40	-	-	-
Research Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling General Administrative	11,069	11,802	3,006	3,006	3,006	10,762	3,006	10,649	9,901	9,523	10,016	8,887	8,887	7,953	8,852	8,749	8,241	8,706	8,319	7,707	7,885	7,679	7,940	7,867	7,665	8,430	6,905	6,686	6,619	7,139	7,270	7,357	6,294	6,620	6,636	7,627	6,864	5,805	5,984	6,366	6,305	6,019	6,391	6,493	6,001	5,821	5,569	6,151	5,649	5,572	5,990	6,090	5,937	5,250	4,545	4,469	4,042	3,872	3,697	3,979	2,768	3,053	3,348	3,559	3,283	3,240	3,251	3,150	3,150	2,961	3,042	3,006	2,011	2,331	2,089	2,185	1,816	1,824	1,850	1,904	1,606	1,564	1,533	1,284	1,468	1,200	1,088	1,274	1,468	1,384	1,129	953	1,511	953	1,087	1,052	1,200	1,100	1,000	900	1,100	1,200	1,200	1,200	0	-	-	-
Tax Provision	2,610	2,163	2,171	2,047	2,830	2,549	2,742	2,894	2,858	2,967	2,950	2,380	1,662	2,088	842	-385	2,667	1,690	2,092	1,664	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Operating Expenses	11,070	13,357	13,487	13,177	11,916	12,058	12,038	11,965	11,258	10,922	11,650	11,504	11,769	9,800	10,257	10,120	9,495	10,136	9,759	9,122	9,352	9,067	9,265	9,150	8,874	9,562	8,044	7,792	7,698	8,225	8,362	8,325	7,294	7,690	7,660	8,642	7,857	6,754	6,910	7,301	7,248	6,926	7,322	7,443	7,094	6,970	6,783	7,394	6,924	6,884	7,225	7,333	7,259	6,475	5,604	5,567	4,971	4,773	4,588	5,090	3,450	3,714	4,024	4,226	3,944	3,912	3,874	3,839	3,839	3,560	3,542	3,476	2,440	2,787	2,543	2,609	2,342	2,362	2,339	2,368	2,083	2,100	2,015	1,730	2,008	1,601	1,506	1,678	2,008	1,893	1,593	1,356	1,799	1,305	1,443	1,325	1,400	1,300	1,200	1,100	1,300	1,300	1,300	1,300	-11,400	-	-	-
Total Other Income Expense Net	-241	-12	-2	-5	-2,770	-262	-432	-264	13	-105	75	21	131	627	-270	630	-132	89	-139	-280	661	-242	493	-28	-27	40	27	9	189	-4	43	74	1,096	-25	2	-1	1	2	7	7	-11	-4	18	14	13	-29	29	-15	-14	74	9	-29	-39	-24	49	-43	-45	-75	-98	41	81	29	-13	-7	8	21	51	-39	-39	7	-10	-14	1	18	-23	-5	31	29	-56	-10	38	5	39	4	-9	-1	-5	-66	-9	-2	-5	-5	-5	-10	-7	-17	-400	100	100	200	300	200	-2,900	300	0	-	-	-
Total Revenue	38,001	37,945	36,161	36,473	38,144	37,691	37,292	38,441	38,298	37,767	36,425	35,464	34,774	33,477	31,166	33,860	32,623	32,465	31,414	31,480	30,639	30,013	28,017	31,017	29,897	28,951	28,435	30,276	28,368	27,032	26,114	27,870	26,365	25,244	24,464	26,270	25,124	23,682	24,001	26,030	22,923	22,407	22,354	24,906	21,996	21,386	20,632	22,407	19,112	18,549	18,316	19,791	15,883	16,006	14,139	17,370	13,842	13,517	13,594	16,740	12,190	13,469	11,901	13,454	10,821	13,952	11,945	10,318	10,318	13,313	10,663	9,476	8,558	10,132	7,150	6,597	6,430	9,320	6,371	7,561	6,742	7,993	6,129	6,058	4,111	7,317	4,800	4,049	4,111	6,105	3,368	4,091	4,206	5,017	4,638	4,455	4,600	5,600	4,300	3,700	4,600	5,600	4,000	3,400	4,600	4,700	3,500	3,400

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	148,580
Cost of Revenue	-61,914
Gross Profit	86,666	86,666

Operating Income (+$)
Gross Profit	86,666
Operating Expense	-46,580
Operating Income	40,086	40,086

Operating Expense (+$)
Research Development	0
Selling General Administrative	46,092
Selling And Marketing Expenses	0
Operating Expense	46,580	46,092

Net Interest Income (+$)
Interest Income	913
Interest Expense	-1,428
Other Finance Cost	-548
Net Interest Income	33

Pretax Income (+$)
Operating Income	40,086
Net Interest Income	33
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	39,962	40,210 EBIT - interestExpense = 38,658 39,962 32,399
Interest Expense	1,428
Earnings Before Interest and Taxes (EBIT)	40,086	41,390
Earnings Before Interest and Taxes (EBITDA)	45,985

After tax Income (+$)
Income Before Tax	39,962
Tax Provision	-9,212
Net Income From Continuing Ops	28,754	30,750
Net Income	30,971
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	108,494
Total Other Income/Expenses Net	-124	-33

Technical Analysis of National Research Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of National Research Corp. The general trend of National Research Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine National Research Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-100.0%)		Bearish trend (100.0%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of National Research Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 33.36 < 35.17 < 35.20.

The bearish price targets are: 31.64 > 30.10 > 29.39.

Tweet this

National Research Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of National Research Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
MA 100 trending down: The MA 100 is trending down. -1
Close < MA 100: The price is below the MA 100. -1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

National Research Corp Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of National Research Corp. The current macd is -1.60433327.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the National Research Corp price going down in the near term. -2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for National Research Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the National Research Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

National Research Corp Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of National Research Corp. The current adx is 31.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell National Research Corp shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.

National Research Corp Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of National Research Corp. The current sar is 35.84.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1

National Research Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of National Research Corp. The current rsi is 20.49. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Trending down: The RSI is trending down. -1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

National Research Corp Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of National Research Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH < 20: The STOCH %K is below 20 and oversold. -2
STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the National Research Corp price going down in the near term. -2
Trending up: The STOCH %K is trending up. +1

National Research Corp Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of National Research Corp. The current cci is -136.41475043.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1

National Research Corp Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of National Research Corp. The current cmo is -68.71937489.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

National Research Corp Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of National Research Corp. The current willr is -97.5308642.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1

National Research Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of National Research Corp.

National Research Corp Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of National Research Corp. The current atr is 1.05434718.

National Research Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of National Research Corp. The current obv is 565,925.

National Research Corp Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of National Research Corp. The current mfi is 24.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

National Research Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for National Research Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-28	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-11-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-06	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2023-12-14	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2023-12-15	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2023-12-18	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-28	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2023-12-29	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-01-02	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-03	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-05	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-08	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-01-09	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-16	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-18	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-23	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-30	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-01	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-02	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-06	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
2024-02-12	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-14	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-16	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-26	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-02-27	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-05	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-06	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-13	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-03-14	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-20	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-22	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-25	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-27	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-28	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-02	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-04	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-05	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-09	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-10	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-17	STOCH	LONG EXIT		The %K line crosses below the %D line.

6.3. Candlestick Patterns

National Research Corp Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of National Research Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	20.489
Ma 20	Greater than	Ma 50	36.903
Ma 50	Greater than	Ma 100	38.584
Ma 100	Greater than	Ma 200	39.285
Open	Greater than	Close	33.160
Total			1/5 (20.0%)

Create your own Symbol Scanner

Get notifications about National Research Corp

I send you an email if I find something interesting about National Research Corp.

National Research Corp Buy, Hold or Sell?

Let's analyse National Research Corp together

Get notifications about National Research Corp

Quick analysis of National Research Corp (30 sec.)

What can you expect buying and holding a share of National Research Corp? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of National Research Corp (5 min.)

$32.87

$1.99

$-3.06 - $13.37

$-1.06 - $15.37

2. Growth of National Research Corp (5 min.)

Is National Research Corp growing?

How much money is National Research Corp making?

How much money comes from the company's main activities?

3. Financial Health of National Research Corp (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

What can you expect buying and holding a share of National Research Corp? (5 min.)

What can you expect buying and holding a share of National Research Corp?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of National Research Corp

About National Research Corp

Financial Health

Valuation

1.1. Profitability of National Research Corp.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Health Information Services)

1.1.2. Return on Assets

Trends

Compared to industry (Health Information Services)

1.1.3. Return on Equity

Trends

Compared to industry (Health Information Services)

1.2. Operating Efficiency of National Research Corp.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Health Information Services)

1.2.2. Operating Ratio

Trends

Compared to industry (Health Information Services)

1.3. Liquidity of National Research Corp.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Health Information Services)

1.3.2. Quick Ratio

Trends

Compared to industry (Health Information Services)

1.4. Solvency of National Research Corp.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Health Information Services)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Health Information Services)

2. Market Valuation of National Research Corp

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Health Information Services)

National Research Corp
Buy, Hold or Sell?